                                  NBER WORKING PAPER SERIES




      MORAL HAZARD AND ECONOMIES OF SCOPE IN PHYSICIAN OWNERSHIP
                 OF COMPLEMENTARY MEDICAL SERVICES

                                              Brian K. Chen
                                              Paul J. Gertler
                                             Chuh-Yuh Yang

                                          Working Paper 19622
                                  http://www.nber.org/papers/w19622


                       NATIONAL BUREAU OF ECONOMIC RESEARCH
                                1050 Massachusetts Avenue
                                  Cambridge, MA 02138
                                     November 2013




The authors have no material or financial interests in the results reported in this paper. The views expressed
herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic
Research.

NBER working papers are circulated for discussion and comment purposes. They have not been peer-
reviewed or been subject to the review by the NBER Board of Directors that accompanies official
NBER publications.

Â© 2013 by Brian K. Chen, Paul J. Gertler, and Chuh-Yuh Yang. All rights reserved. Short sections
of text, not to exceed two paragraphs, may be quoted without explicit permission provided that full
credit, including Â© notice, is given to the source.
Moral Hazard and Economies of Scope in Physician Ownership of Complementary Medical
Services
Brian K. Chen, Paul J. Gertler, and Chuh-Yuh Yang
NBER Working Paper No. 19622
November 2013
JEL No. I11,I12,K23,L22

                                              ABSTRACT

When physicians own complementary medical service facilities such as clinical laboratories and imaging
centers, they gain financially by referring patients to these service entities. This situation creates an
incentive for the physician to exploit the consumersâ€™ trust by recommending more services than they
would demand under full information. This moral hazard cost, however, may be offset by gains in
economies of scope if the complementary services are integrated into the physicianâ€™s practice. We
assess the extent of moral hazard and economies of scope using data from Taiwan, which introduced
a â€œseparatingâ€ policy, similar to the Stark Law in the US, that restricts physician ownership of pharmacies
unless they are fully integrated into the physicianâ€™s practice. We find that physicians who own pharmacies
prescribe 7.6% more drugs than those who do not own pharmacies. Overall, we find no evidence of
economies of scope from integration in the treatment of patients with acute respiratory infections,
diabetes, or hypertension. Overall the separating policy was ineffective at controlling drug costs as
a large number of physicians choose to integrate pharmacies into their practices in order to become
exempt from the policy.


Brian K. Chen                                        Chuh-Yuh Yang
University of South Carolina                         Kaohsiung Medical University
bchen@mailbox.sc.edu                                 Kaohsiung, Taiwan
                                                     chunyuh@kmu.edu.tw
Paul J. Gertler
Haas School of Business
University of California, Berkeley
Berkeley, CA 94720
and NBER
gertler@haas.berkeley.edu
                                                                                                                                                                                                                                                                            	 Â 


1. Introduction	 Â 

	 Â                     Consumers	 Â  often	 Â  turn	 Â  to	 Â  experts	 Â  for	 Â  advice	 Â  when	 Â  they	 Â  have	 Â  difficulty	 Â  discerning	 Â  the	 Â 
extent	 Â  to	 Â  which	 Â  goods	 Â  and	 Â  services	 Â  meet	 Â  their	 Â  needs	 Â  such	 Â  as	 Â  in	 Â  cases	 Â  of	 Â  automotive	 Â  and	 Â 
appliance	 Â repair,	 Â engineering	 Â services,	 Â financial	 Â services,	 Â and	 Â medical	 Â care.	 Â These	 Â experts	 Â 
not	 Â  only	 Â  give	 Â  advice	 Â  but	 Â  also	 Â  sell	 Â  goods	 Â  and	 Â  services	 Â  to	 Â  consumers	 Â  based	 Â  on	 Â  that	 Â  advice.	 Â 
This	 Â  situation	 Â  creates	 Â  an	 Â  incentive	 Â  for	 Â  the	 Â  expert	 Â  to	 Â  exploit	 Â  consumersâ€™	 Â  trust	 Â  and	 Â 
recommend	 Â  more	 Â  services	 Â  than	 Â  they	 Â  would	 Â  demand	 Â  under	 Â  full	 Â  information	 Â  (Taylor	 Â  1995	 Â 
and	 Â  Wolinsky	 Â  1993).	 Â  This	 Â  moral	 Â  hazard	 Â  cost,	 Â  however,	 Â  maybe	 Â  offset	 Â  by	 Â  gains	 Â  in	 Â  economies	 Â 
of	 Â scope	 Â from	 Â the	 Â diagnostician	 Â also	 Â providing	 Â the	 Â services	 Â (Afendulis	 Â and	 Â Kessler	 Â 2007).	 Â 	 Â 
	 Â                     This	 Â  moral	 Â  hazard	 Â  inherent	 Â  in	 Â  such	 Â  â€œcredenceâ€	 Â  goods	 Â  is	 Â  present	 Â  in	 Â  physician	 Â 
ownership	 Â  of	 Â  complementary	 Â  medical	 Â  service	 Â  facilities	 Â  such	 Â  as	 Â  clinical	 Â  laboratories,	 Â 
imaging	 Â  centers	 Â  (i.e.,	 Â  X-Â­â€rays,	 Â  CAT	 Â  scans	 Â  and	 Â  MRIs),	 Â  pharmacies	 Â  and	 Â  physical	 Â  therapy	 Â 
centers.	 Â  Physicians	 Â  gain	 Â  financially	 Â  by	 Â  referring	 Â  patients	 Â  to	 Â  a	 Â  complementary	 Â  service	 Â  entity	 Â 
in	 Â  which	 Â  the	 Â  physician	 Â  has	 Â  a	 Â  financial	 Â  interest.	 Â  Patients,	 Â  who	 Â  rely	 Â  on	 Â  physicians	 Â  for	 Â  medical	 Â 
advice,	 Â  have	 Â  little	 Â  incentive	 Â  to	 Â  reject	 Â  prescribed	 Â  procedures	 Â  especially	 Â  when	 Â  insurance	 Â 
covers	 Â  most	 Â  of	 Â  the	 Â  cost.	 Â  Because	 Â  patients	 Â  have	 Â  imperfect	 Â  information	 Â  on	 Â  the	 Â  scope	 Â  of	 Â  the	 Â 
problem,	 Â  diagnosticians	 Â  have	 Â  incentive	 Â  to	 Â  recommend	 Â  procedures	 Â  that	 Â  are	 Â  profitable	 Â 
regardless	 Â of	 Â their	 Â cost	 Â or	 Â appropriateness.	 Â 	 Â                                                                                                                                                                                                   	 Â 
	 Â                     To	 Â combat	 Â these	 Â moral	 Â hazard	 Â or	 Â â€œself	 Â referralâ€	 Â abuses,	 Â Congress	 Â passed	 Â the	 Â Stark	 Â 
Law	 Â  in	 Â  1989,	 Â  which	 Â  prohibits	 Â  physician	 Â  referrals	 Â  of	 Â  Medicare	 Â  and	 Â  Medicaid	 Â  patients	 Â  to	 Â 
complementary	 Â care	 Â facilities	 Â in	 Â which	 Â the	 Â physician	 Â or	 Â members	 Â of	 Â the	 Â physicianâ€™s	 Â group	 Â 
have	 Â  a	 Â  financial	 Â  interest.1	 Â The	 Â  Law	 Â  has	 Â  a	 Â  â€œsafe	 Â  harborâ€	 Â  exception	 Â  that	 Â  permits	 Â  physicians	 Â  to	 Â 
escape	 Â prohibition	 Â if	 Â the	 Â self-Â­â€referral	 Â is	 Â for	 Â services	 Â provided	 Â within	 Â physician	 Â offices	 Â by	 Â a	 Â 
â€œbona	 Â  fide	 Â  employee.â€	 Â  In	 Â  other	 Â  words,	 Â  the	 Â  Law	 Â  draws	 Â  a	 Â  distinction	 Â  between	 Â  permissible	 Â 
referrals	 Â  made	 Â  within	 Â  an	 Â  integrated	 Â  firm	 Â  and	 Â  impermissible	 Â  referrals	 Â  made	 Â  to	 Â  outside	 Â 
entities.	 Â  Presumably,	 Â  the	 Â  exception	 Â  for	 Â  integrated	 Â  organizations	 Â  is	 Â  based	 Â  on	 Â  potential	 Â 
economies	 Â  of	 Â  scope	 Â  from	 Â  the	 Â  joint	 Â  production	 Â  of	 Â  physician	 Â  and	 Â  complementary	 Â  medical	 Â 


             	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
1
 The Stark Law prohibits clinical laboratory, physical and occupational therapy, radiology, radiation therapy,
medical equipment and supplies, nutrients, prosthetics, home health, prescription drugs, and hospital services.
2
	 Â See	 Â Medicare Part B Imaging Services: Rapid Growth and Shift to Physician Offices Indicate Need for CMS to
Consider Additional Management Practices, GAO-08-452, June 2008. See also â€œMedPAC Seeks to Further Stop In-
Office Imaging Incentives,â€ HealthImaging.com, June 21, 2010.
                                                                                                                                                                                                                                                                 1
3
       	 Â See	 Â Medicare: Trends in Fees, Utilization, Expenditures for Imaging Services before and after Implementation of
                                                                                                                                                                                                                                                                 	 Â 


services.	 Â  Indeed,	 Â  economies	 Â  of	 Â  scope	 Â  may	 Â  arise	 Â  from	 Â  better	 Â  coordination	 Â  of	 Â  care	 Â  and	 Â 
thereby	 Â improve	 Â patient	 Â outcomes	 Â (Afendulis	 Â and	 Â Kessler,	 Â 2007).	 Â 	 Â 
	 Â                 However,	 Â the	 Â safe	 Â harbor	 Â exception	 Â also	 Â allows	 Â physicians	 Â to	 Â circumvent	 Â the	 Â intent	 Â 
of	 Â the	 Â Stark	 Â law	 Â by	 Â integrating	 Â complementary	 Â services	 Â directly	 Â into	 Â their	 Â practices.	 Â In	 Â fact,	 Â 
there	 Â  has	 Â  been	 Â  massive	 Â  integration	 Â  of	 Â  such	 Â  services	 Â  into	 Â  physician	 Â  groups	 Â  since	 Â  the	 Â 
enactment	 Â of	 Â the	 Â Stark	 Â Law	 Â (Tynan	 Â et	 Â al.,	 Â 2008,	 Â United	 Â States	 Â Government	 Â Accountability	 Â 
Office,	 Â 2008).	 Â For	 Â instance,	 Â over	 Â the	 Â last	 Â two	 Â decades	 Â 27%	 Â of	 Â physician	 Â groups	 Â expanded	 Â in-Â­â€
office	 Â imaging	 Â services.	 Â 2	 Â And	 Â Medicare	 Â spending	 Â for	 Â imaging	 Â services	 Â increased	 Â on	 Â average	 Â 
13%	 Â per	 Â year,	 Â with	 Â over	 Â two-Â­â€thirds	 Â of	 Â the	 Â spending	 Â occurring	 Â in	 Â physician	 Â office	 Â settings.3	 Â 
	 Â                 Policy	 Â makers	 Â are	 Â keenly	 Â aware	 Â of	 Â the	 Â problems	 Â with	 Â the	 Â exemption.	 Â The	 Â Medicare	 Â 
Patient	 Â Advisory	 Â Commission	 Â recently	 Â proposed	 Â extensive	 Â changes	 Â to	 Â limit	 Â the	 Â exemption.	 Â 
And	 Â  the	 Â  Center	 Â  for	 Â  Medicare	 Â  and	 Â  Medicaid	 Â  Services	 Â  recommended	 Â  that	 Â  physicians	 Â  who	 Â 
make	 Â self-Â­â€referrals	 Â must	 Â disclose	 Â their	 Â financial	 Â interests	 Â to	 Â patients	 Â in	 Â a	 Â June,	 Â 2010	 Â Report	 Â 
to	 Â Congress	 Â under	 Â the	 Â Patient	 Â Protection	 Â and	 Â Affordable	 Â Care	 Â Act	 Â of	 Â 2010.	 Â 
	 Â                 In	 Â this	 Â paper,	 Â we	 Â use	 Â data	 Â from	 Â Taiwan	 Â to	 Â estimate	 Â the	 Â moral	 Â hazard	 Â costs	 Â and	 Â gains	 Â 
from	 Â  economies	 Â  of	 Â  scope	 Â  associated	 Â  with	 Â  physician	 Â  ownership	 Â  of	 Â  pharmacies.	 Â  For	 Â 
identification,	 Â  we	 Â  exploit	 Â  a	 Â  policy	 Â  prohibiting	 Â  physicians	 Â  from	 Â  owning	 Â  pharmacies	 Â  and	 Â 
dispensing	 Â  drugs	 Â  that	 Â  was	 Â  phased	 Â  in	 Â  geographically	 Â  over	 Â  time.	 Â  The	 Â  â€œseparatingâ€	 Â  policy	 Â 
included	 Â a	 Â safe	 Â harbor	 Â exemption	 Â for	 Â physician	 Â groups	 Â that	 Â have	 Â an	 Â onsite	 Â pharmacy	 Â with	 Â a	 Â 
licensed	 Â  pharmacist	 Â  integrated	 Â  into	 Â  their	 Â  practice,	 Â  which	 Â  is	 Â  identical	 Â  to	 Â  the	 Â  safe	 Â  harbor	 Â 
provision	 Â in	 Â the	 Â Stark	 Â Law.	 Â 	 Â 
	 Â                 Our	 Â analysis	 Â is	 Â made	 Â possible	 Â by	 Â a	 Â novel	 Â data	 Â set	 Â the	 Â links	 Â patient	 Â claims	 Â over	 Â time	 Â 
to	 Â medical	 Â care	 Â providers	 Â for	 Â the	 Â universe	 Â of	 Â patients	 Â and	 Â providers.	 Â 	 Â Taiwan	 Â is	 Â a	 Â country	 Â 
with	 Â  OECD	 Â  level	 Â  income	 Â  and	 Â  health	 Â  status	 Â  indicators.	 Â  It	 Â  also	 Â  has	 Â  a	 Â  sophisticated	 Â  health	 Â  care	 Â 
delivery	 Â  system	 Â  with	 Â  a	 Â  universal	 Â  single-Â­â€payer	 Â  health	 Â  insurance	 Â  system	 Â  similar	 Â  to	 Â  Canada	 Â 
(Lu	 Â and	 Â Hsiao,	 Â 2003).	 Â The	 Â single	 Â payer	 Â insurance	 Â plan	 Â maintains	 Â individual	 Â claims	 Â data	 Â that	 Â 
can	 Â be	 Â linked	 Â over	 Â time	 Â and	 Â to	 Â providers.	 Â 	 Â 
         	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
2
	 Â See	 Â Medicare Part B Imaging Services: Rapid Growth and Shift to Physician Offices Indicate Need for CMS to
Consider Additional Management Practices, GAO-08-452, June 2008. See also â€œMedPAC Seeks to Further Stop In-
Office Imaging Incentives,â€ HealthImaging.com, June 21, 2010.
3
 	 Â See	 Â Medicare: Trends in Fees, Utilization, Expenditures for Imaging Services before and after Implementation of
the Deficit Reduction Act of 2005, GAO-08-1102R, September 26, 2008.



                                                                                                                                                                                                                                                             2
                                                                                                                                                                                                                                                                  	 Â 


	 Â                     We	 Â  estimate	 Â  that	 Â  the	 Â  separating	 Â  policy	 Â  significantly	 Â  reduced	 Â  drug	 Â  expenditures	 Â 
among	 Â physicians	 Â that	 Â did	 Â not	 Â have	 Â an	 Â onsite	 Â pharmacy.	 Â However,	 Â the	 Â effect	 Â of	 Â the	 Â policy	 Â 
on	 Â  reducing	 Â  the	 Â  total	 Â  costs	 Â  of	 Â  care	 Â  was	 Â  substantially	 Â  smaller	 Â  for	 Â  a	 Â  number	 Â  of	 Â  reasons.	 Â  First,	 Â 
physicians	 Â  responded	 Â  by	 Â  increasing	 Â  the	 Â  overprovision	 Â  of	 Â  self-Â­â€referred	 Â  diagnostic	 Â  services	 Â 
not	 Â covered	 Â by	 Â the	 Â policy.	 Â Second,	 Â more	 Â than	 Â half	 Â of	 Â the	 Â physician	 Â groups	 Â (clinics)	 Â already	 Â 
had	 Â an	 Â onsite	 Â pharmacy	 Â prior	 Â to	 Â the	 Â policy	 Â and	 Â therefore	 Â were	 Â exempt.	 Â Third,	 Â close	 Â to	 Â 40%	 Â 
of	 Â  the	 Â  clinics	 Â  that	 Â  did	 Â  not	 Â  have	 Â  an	 Â  onsite	 Â  pharmacy	 Â  prior	 Â  to	 Â  the	 Â  policy	 Â  integrated	 Â  onsite	 Â 
pharmacies	 Â into	 Â their	 Â practices	 Â after	 Â the	 Â implementation	 Â of	 Â the	 Â policy.	 Â 	 Â 	 Â 
	 Â                     Our	 Â  results	 Â  show	 Â  that	 Â  policymakers	 Â  are	 Â  correct	 Â  to	 Â  be	 Â  concerned	 Â  about	 Â  physicians	 Â 
referring	 Â patients	 Â to	 Â an	 Â entity	 Â in	 Â which	 Â they	 Â have	 Â a	 Â financial	 Â interest.	 Â We	 Â find	 Â evidence	 Â of	 Â 
significant	 Â moral	 Â hazard	 Â as	 Â owning	 Â a	 Â pharmacy	 Â increased	 Â physician	 Â drug	 Â prescriptions	 Â by	 Â 
7.6%.	 Â In	 Â contrast,	 Â we	 Â find	 Â no	 Â evidence	 Â to	 Â support	 Â any	 Â gains	 Â due	 Â to	 Â economies	 Â of	 Â scope	 Â from	 Â 
the	 Â  integration	 Â  of	 Â  pharmacies	 Â  into	 Â  physician	 Â  offices.	 Â  First,	 Â  integration	 Â  failed	 Â  to	 Â  create	 Â 
efficiency	 Â  savings;	 Â  indeed,	 Â  it	 Â  generated	 Â  the	 Â  opposite	 Â  result,	 Â  as	 Â  moral	 Â  hazard	 Â  effects	 Â 
dominate.	 Â Second,	 Â integration	 Â did	 Â not	 Â improve	 Â adherence	 Â to	 Â medication	 Â prescriptions	 Â for	 Â 
patients	 Â with	 Â the	 Â chronic	 Â diseases	 Â diabetes	 Â and	 Â hypertension.	 Â Finally,	 Â we	 Â find	 Â no	 Â effect	 Â of	 Â 
integration	 Â on	 Â preventable	 Â adverse	 Â medical	 Â events	 Â in	 Â the	 Â treatment	 Â of	 Â patients	 Â with	 Â acute	 Â 
respiratory	 Â infections,	 Â diabetes,	 Â and	 Â hypertension.	 Â This	 Â the	 Â safe	 Â harbor	 Â exception	 Â severely	 Â 
limited	 Â the	 Â policyâ€™s	 Â effectiveness	 Â as	 Â physicians	 Â exploited	 Â the	 Â loophole	 Â to	 Â be	 Â able	 Â to	 Â continue	 Â 
to	 Â engage	 Â in	 Â profitable	 Â self-Â­â€referrals	 Â without	 Â any	 Â off	 Â setting	 Â gains	 Â from	 Â economies	 Â of	 Â scope.	 Â 
	 Â                     Our	 Â  work	 Â  makes	 Â  several	 Â  contributions	 Â  to	 Â  the	 Â  understanding	 Â  of	 Â  health	 Â  care	 Â  markets.	 Â 
First,	 Â  we	 Â  among	 Â  the	 Â  first	 Â  to	 Â  provide	 Â  empirical	 Â  evidence	 Â  of	 Â  a	 Â  causal	 Â  role	 Â  of	 Â  self-Â­â€referral	 Â 
incentives	 Â in	 Â the	 Â overprovision	 Â of	 Â complementary	 Â medical	 Â care	 Â services.4	 Â Second,	 Â our	 Â work	 Â 
is	 Â among	 Â the	 Â first	 Â to	 Â empirically	 Â examine	 Â policies	 Â such	 Â as	 Â the	 Â Stark	 Â Law	 Â that	 Â regulate	 Â self-Â­â€
referrals	 Â abuse.	 Â Third,	 Â our	 Â work	 Â is	 Â first	 Â to	 Â examine	 Â the	 Â effect	 Â of	 Â policies	 Â such	 Â as	 Â the	 Â Stark	 Â 
Law	 Â on	 Â the	 Â organizational	 Â structure	 Â of	 Â the	 Â industry.	 Â 


                  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
4
       	 Â Most	 Â of	 Â the	 Â work	 Â reports	 Â cross-Â­â€sectional	 Â correlations	 Â that	 Â are	 Â consistent	 Â with	 Â the	 Â overtreatment	 Â hypothesis.
For example see Childs and Hunter (1972), Strasser et al (1987), Hillman et al (1990, 1995, 1992), Aronovitz (1994),
Mitchell and Sass (1995), Gazelle et al (2007), Mitchell (2005) and Mitchell	 Â (2008).	 Â One	 Â important	 Â exception	 Â is	 Â 
Iizuka	 Â (2007)	 Â who	 Â shows	 Â that	 Â physicians	 Â who	 Â dispense	 Â their	 Â own	 Â drugs	 Â in	 Â Japan	 Â take	 Â a	 Â drugâ€™s	 Â markup	 Â into	 Â 
account	 Â in	 Â prescription	 Â decisions.


                                                                                                                                          3
                                                                                                                                                        	 Â 


	 Â         Our	 Â work	 Â also	 Â contributes	 Â to	 Â the	 Â more	 Â general	 Â literature	 Â on	 Â moral	 Â hazard	 Â concerns	 Â 
that	 Â  arise	 Â  in	 Â  credence	 Â  good	 Â  markets.	 Â  Chevalier	 Â  and	 Â  Ellison	 Â  (1997)	 Â  find	 Â  that	 Â  mutual	 Â  fund	 Â 
managers	 Â often	 Â try	 Â to	 Â increase	 Â the	 Â inflow	 Â of	 Â funds	 Â against	 Â the	 Â interests	 Â of	 Â their	 Â customers.	 Â 
Hubbard	 Â  (1998,	 Â  2002)	 Â  investigates	 Â  the	 Â  California	 Â  vehicle	 Â  emissions	 Â  inspection	 Â  market	 Â 
where	 Â  inspectors	 Â  also	 Â  provide	 Â  repairs	 Â  to	 Â  help	 Â  vehicles	 Â  pass.	 Â  Levitt	 Â  and	 Â  Syverson	 Â  (2008)	 Â 
show	 Â that	 Â homes	 Â owned	 Â by	 Â real	 Â estate	 Â agents	 Â sell	 Â for	 Â higher	 Â prices	 Â than	 Â comparable	 Â homes	 Â 
owned	 Â  by	 Â  non-Â­â€agents.	 Â  Gruber	 Â  and	 Â  Owings	 Â  (1996)	 Â  document	 Â  a	 Â  negative	 Â  relationship	 Â 
between	 Â birth	 Â rate	 Â and	 Â Cesarean	 Â section	 Â delivery	 Â as	 Â evidence	 Â of	 Â physician-Â­â€induced	 Â demand	 Â 
for	 Â costly	 Â procedures.	 Â 	 Â Iizuka	 Â (2007)	 Â shows	 Â that	 Â physicians	 Â who	 Â dispense	 Â their	 Â own	 Â drugs	 Â 
in	 Â  Japan	 Â  take	 Â  a	 Â  drugâ€™s	 Â  markup	 Â  into	 Â  account	 Â  in	 Â  prescription	 Â  decisions. Finally,	 Â  Afendulis	 Â  and	 Â 
Kessler	 Â (2007)	 Â examine	 Â the	 Â tradeoffs	 Â between	 Â moral	 Â hazard	 Â and	 Â economies	 Â of	 Â scope	 Â in	 Â the	 Â 
joint	 Â production	 Â of	 Â diagnosis	 Â and	 Â treatment	 Â of	 Â cardiac	 Â conditions.	 Â 

2.          Conceptual	 Â Framework	 Â 

            We	 Â model	 Â the	 Â prohibition	 Â against	 Â self-Â­â€referrals	 Â as	 Â a	 Â fee	 Â reduction	 Â in	 Â complementary	 Â 
services	 Â  that	 Â  the	 Â  physician	 Â  prescribes	 Â  (recommends)	 Â  to	 Â  patients.	 Â  Suppose	 Â  physicians	 Â 
prescribe	 Â  two	 Â  types	 Â  of	 Â  complementary	 Â  services:	 Â  (1)	 Â  services	 Â  that	 Â  are	 Â  subject	 Â  to	 Â  the	 Â 
prohibition	 Â such	 Â  as	 Â  drugs	 Â  and	 Â  (2)	 Â  services	 Â  that	 Â  are	 Â  not	 Â  subject	 Â  to	 Â  the	 Â  prohibition	 Â  such	 Â  as	 Â 
imaging.	 Â  	 Â  Physician	 Â  income	 Â  from	 Â  complementary	 Â  services	 Â  can	 Â  be	 Â  represented	 Â  simply	 Â  as	 Â 
ğ‘Œ = ğ‘ ğœ‹! ğ‘ ! ğ‘¤! + ğœ‹! ğ‘ ! ğ‘¤! 	 Â where	 Â  N	 Â  is	 Â  the	 Â  number	 Â  of	 Â  patients	 Â  she	 Â  sees,	 Â ğœ‹! 	 Â is	 Â  the	 Â  profit	 Â 
margins	 Â for	 Â service	 Â i,	 Â and	 Â ğ‘ ! 	 Â is	 Â the	 Â quantity	 Â of	 Â service	 Â i	 Â provided,	 Â which	 Â depend	 Â on	 Â wi	 Â â€“	 Â the	 Â 
amount	 Â of	 Â overtreatment.	 Â If	 Â the	 Â physician	 Â provides	 Â the	 Â clinically	 Â appropriate	 Â level	 Â of	 Â care,	 Â 
then	 Â the	 Â level	 Â of	 Â overtreatment	 Â is	 Â zero.	 Â 
            Physicians	 Â  gain	 Â  income	 Â  from	 Â  over-Â­â€treating	 Â  patients,	 Â  but	 Â  pay	 Â  a	 Â  cost	 Â  in	 Â  terms	 Â  of	 Â 
disutility.	 Â  Before	 Â  the	 Â  prohibition,	 Â  the	 Â  equilibrium	 Â  amount	 Â  of	 Â  overtreatment	 Â  equates	 Â  the	 Â 
marginal	 Â  income	 Â  from	 Â  overtreatment	 Â  of	 Â  each	 Â  service	 Â  to	 Â  the	 Â  marginal	 Â  disutility	 Â  from	 Â  total	 Â 
overtreatment.	 Â The	 Â prohibition	 Â reduces	 Â the	 Â profit	 Â margin	 Â for	 Â drugs,	 Â ğœ‹! ,	 Â to	 Â zero.	 Â In	 Â this	 Â case,	 Â 
the	 Â  physician	 Â  prescribes	 Â  only	 Â  the	 Â  amount	 Â  of	 Â  drugs	 Â  needed	 Â  and	 Â  overprovision	 Â  of	 Â  drugs	 Â  is	 Â 
zero.	 Â  However,	 Â  the	 Â  physician	 Â  increases	 Â  over-Â­â€provision	 Â  of	 Â  non-Â­â€prohibited	 Â  services	 Â  from	 Â 
which	 Â she	 Â still	 Â has	 Â a	 Â positive	 Â return.	 Â 	 Â 



                                                                               4
                                                                                                                                                                                                                       	 Â 


            Physicians	 Â  with	 Â  an	 Â  onsite	 Â  pharmacy	 Â  are	 Â  de	 Â  jure	 Â  exempt	 Â  from	 Â  the	 Â  prohibition	 Â  and	 Â 
there	 Â is	 Â no	 Â impact	 Â of	 Â the	 Â policy	 Â on	 Â their	 Â overprovision	 Â of	 Â drugs.	 Â One	 Â option	 Â for	 Â those	 Â that	 Â 
do	 Â  not	 Â  have	 Â  onsite	 Â  pharmacy	 Â  is	 Â  for	 Â  them	 Â  to	 Â  legally	 Â  circumvent	 Â  the	 Â  prohibition	 Â  policy	 Â  by	 Â 
integrating	 Â  a	 Â  pharmacy	 Â  into	 Â  their	 Â  practice.	 Â  However,	 Â  having	 Â  a	 Â  pharmacy	 Â  requires	 Â  paying	 Â 
the	 Â fixed	 Â costs	 Â that	 Â include	 Â salary,	 Â space,	 Â equipment,	 Â and	 Â training.	 Â 	 Â 	 Â 
            The	 Â  physician	 Â  integrates	 Â  a	 Â  pharmacy	 Â  into	 Â  her	 Â  medical	 Â  practice	 Â  if	 Â  the	 Â  profits	 Â  from	 Â 
having	 Â  an	 Â  onsite	 Â  pharmacy	 Â  are	 Â  larger	 Â  than	 Â  not	 Â  having	 Â  one.	 Â  	 Â  The	 Â  net	 Â  income	 Â  from	 Â 
integration	 Â  is	 Â ğ‘Œ !! = ğ‘ ğœ‹! ğ‘ ! ğ‘¤!âˆ— + ğœ‹! ğ‘ ! ğ‘¤!âˆ—                       âˆ’ ğ¹,	 Â  where	 Â  F	 Â  is	 Â  the	 Â  fixed	 Â  cost	 Â  of	 Â  having	 Â  a	 Â 
pharmacy	 Â and	 Â ğ‘¤!âˆ— 	 Â is	 Â the	 Â optimal	 Â overprovision.	 Â The	 Â income	 Â generated	 Â without	 Â a	 Â pharmacy	 Â 
is	 Â  ğ‘Œ !" = ğ‘ğœ‹! ğ‘ ! ğ‘¤!! 	 Â where	 Â  ğ‘¤!! 	 Â is	 Â  the	 Â  optimal	 Â  overprovision	 Â  under	 Â  the	 Â  prohibition.	 Â  A	 Â 
physician,	 Â then,	 Â hires	 Â a	 Â pharmacy	 Â if	 Â ğ‘Œ !! âˆ’ ğ‘Œ !" > 0,	 Â which	 Â translates	 Â into	 Â 

                                                                      F
                                       ğ‘>                                                       Â  Â  Â  Â  Â  Â  Â  Â  Â . Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â (1)	 Â 
                                                Ï€1 s1 w1*       +Ï€2 s2 w2* -Â­â€Ï€2 s2 w2'
	 Â 
The	 Â physician	 Â will	 Â integrate	 Â if	 Â the	 Â number	 Â of	 Â patients	 Â is	 Â larger	 Â than	 Â the	 Â fixed	 Â cost	 Â divided	 Â 
by	 Â the	 Â per-Â­â€patient	 Â marginal	 Â profit	 Â from	 Â having	 Â an	 Â onsite	 Â pharmacy.	 Â The	 Â larger	 Â the	 Â fixed	 Â 
costs	 Â and	 Â the	 Â lower	 Â the	 Â return	 Â to	 Â overprovision,	 Â the	 Â greater	 Â the	 Â number	 Â of	 Â patients	 Â 
required	 Â for	 Â integration	 Â to	 Â be	 Â profitable.	 Â In	 Â other	 Â words,	 Â there	 Â needs	 Â to	 Â be	 Â sufficient	 Â scale	 Â 
to	 Â be	 Â able	 Â to	 Â cover	 Â the	 Â fixed	 Â costs.	 Â 
            The	 Â framework	 Â provides	 Â us	 Â with	 Â a	 Â number	 Â of	 Â empirically	 Â testable	 Â predictions.	 Â First,	 Â 
the	 Â  prohibition	 Â  policy	 Â  will	 Â  reduce	 Â  drug	 Â  prescriptions	 Â  by	 Â  physicians	 Â  in	 Â  clinics	 Â  that	 Â  do	 Â  not	 Â 
have	 Â  a	 Â  pharmacy	 Â  on	 Â  site.	 Â  Second,	 Â  moral	 Â  hazard	 Â  from	 Â  self-Â­â€referral	 Â  incentives	 Â  is	 Â  the	 Â 
difference	 Â  in	 Â  drug	 Â  expenditures	 Â  for	 Â  patients	 Â  who	 Â  are	 Â  treated	 Â  by	 Â  physicians	 Â  with	 Â  and	 Â 
without	 Â an	 Â onsite	 Â pharmacy.	 Â Third,	 Â the	 Â policy	 Â will	 Â increase	 Â the	 Â over-Â­â€provision	 Â of	 Â other	 Â non-Â­â€
prohibited	 Â  complementary	 Â  services	 Â  meaning	 Â  that	 Â  any	 Â  efficiency	 Â  gains	 Â  from	 Â  reducing	 Â 
unnecessary	 Â  drug	 Â  prescriptions	 Â  will	 Â  be	 Â  at	 Â  least	 Â  partially	 Â  offset	 Â  by	 Â  increases	 Â  in	 Â  other	 Â 
services.	 Â  Third,	 Â  the	 Â  exemption	 Â  to	 Â  the	 Â  prohibition	 Â  gives	 Â  clinics	 Â  an	 Â  incentive	 Â  to	 Â  integrate	 Â 
pharmacies	 Â into	 Â their	 Â practice	 Â to	 Â circumvent	 Â the	 Â prohibition	 Â if	 Â they	 Â have	 Â sufficient	 Â patient	 Â 
volume	 Â to	 Â cover	 Â the	 Â fixed	 Â costs.	 Â 	 Â 




                                                                             5
                                                                                                                                                  	 Â 


3. Institutional	 Â Context	 Â 

	 Â        Taiwan	 Â is	 Â a	 Â country	 Â of	 Â 23	 Â million	 Â people	 Â that	 Â has	 Â an	 Â advanced	 Â market	 Â economy	 Â with	 Â 
a	 Â per	 Â capita	 Â GDP	 Â of	 Â US$32,200.	 Â Taiwanâ€™s	 Â health	 Â indicators	 Â are	 Â on	 Â par	 Â with	 Â OECD	 Â nations:	 Â 
Life	 Â expectancy	 Â in	 Â Taiwan	 Â is	 Â 72	 Â for	 Â men	 Â and	 Â 78	 Â for	 Â women,	 Â and	 Â infant	 Â mortality	 Â is	 Â 6.14	 Â per	 Â 
1,000	 Â live	 Â births.	 Â Taiwanâ€™s	 Â health	 Â care	 Â infrastructure	 Â is	 Â also	 Â comparable	 Â to	 Â those	 Â of	 Â many	 Â 
OECD	 Â  countries,	 Â  with	 Â  5.7	 Â  hospital	 Â  beds	 Â  and	 Â  8.7	 Â  medical	 Â  professionals	 Â  per	 Â  1,000	 Â  (Lu	 Â  and	 Â 
Hsiao,	 Â  2003).	 Â  By	 Â  2007,	 Â  total	 Â  health	 Â  expenditures	 Â  represented	 Â  6.3%	 Â  of	 Â  Taiwanâ€™s	 Â  GDP,	 Â  of	 Â 
which	 Â 21%	 Â consisted	 Â of	 Â prescription	 Â drug	 Â expenditures.	 Â 
       Taiwanâ€™s	 Â health	 Â care	 Â system,	 Â modeled	 Â after	 Â Canada,	 Â is	 Â publicly	 Â financed	 Â with	 Â patients	 Â 
free	 Â  to	 Â  choose	 Â  among	 Â  a	 Â  mixture	 Â  of	 Â  private	 Â  and	 Â  public	 Â  medical	 Â  care	 Â  providers.	 Â  Taiwanâ€™s	 Â 
National	 Â  Health	 Â  Insurance	 Â  has	 Â  achieved	 Â  universal	 Â  enrollment	 Â  for	 Â  a	 Â  comprehensive	 Â  package	 Â 
of	 Â medical	 Â services.	 Â Virtually	 Â all	 Â health	 Â care	 Â providers	 Â are	 Â under	 Â contract	 Â with	 Â the	 Â National	 Â 
Health	 Â  Insurance	 Â  Bureau	 Â  (NHIB),	 Â  which	 Â  pays	 Â  physicians	 Â  fee-Â­â€for-Â­â€service	 Â  for	 Â  consultations,	 Â 
diagnostic	 Â tests	 Â performed	 Â in	 Â the	 Â office,	 Â and	 Â writing	 Â drug	 Â prescriptions	 Â (Cheng,	 Â 2003).	 Â 	 Â 
        Prior	 Â  to	 Â  1997,	 Â  physicians	 Â  were	 Â  also	 Â  allowed	 Â  to	 Â  dispense	 Â  drugs	 Â  directly	 Â  out	 Â  of	 Â  their	 Â 
offices	 Â (Wagstaff,	 Â 2007).	 Â NHIB	 Â paid	 Â physicians	 Â for	 Â dispensing	 Â drugs	 Â based	 Â on	 Â a	 Â set	 Â of	 Â fixed	 Â 
formulary	 Â  fees.	 Â  Physicians,	 Â  however,	 Â  were	 Â  able	 Â  to	 Â  procure	 Â  the	 Â  drugs	 Â  directly	 Â  from	 Â 
manufacturers	 Â at	 Â a	 Â much	 Â lower	 Â cost	 Â than	 Â the	 Â NHI	 Â formulary	 Â prices	 Â (Eggleston,	 Â 2009).	 Â As	 Â a	 Â 
result,	 Â physicians	 Â reaped	 Â handsome	 Â profits	 Â from	 Â the	 Â sale	 Â of	 Â drugs.	 Â 	 Â 
        In	 Â  1997,	 Â  facing	 Â  rapidly	 Â  rising	 Â  prescription	 Â  drug	 Â  expenditures,	 Â  Taiwan	 Â  instituted	 Â  an	 Â 
anti-Â­â€self-Â­â€referrals	 Â policy	 Â called	 Â the	 Â â€œseparatingâ€	 Â policy,	 Â designed	 Â to	 Â disentangle	 Â physiciansâ€™	 Â 
diagnosis	 Â and	 Â treatment	 Â decisions	 Â from	 Â the	 Â financial	 Â incentive	 Â to	 Â prescribe	 Â drugs	 Â (Chou	 Â et	 Â 
al.,	 Â  2003).	 Â  The	 Â  â€œseparatingâ€	 Â  policy	 Â  prohibited	 Â  clinics	 Â  from	 Â  dispensing	 Â  drugs	 Â  directly	 Â  by	 Â 
physicians	 Â from	 Â their	 Â offices	 Â and	 Â physicians	 Â from	 Â owning	 Â offsite	 Â pharmacies.	 Â 	 Â 
        There	 Â were	 Â a	 Â number	 Â of	 Â exceptions.	 Â First,	 Â like	 Â the	 Â Stark	 Â Lawâ€™s	 Â safe	 Â harbor	 Â exception,	 Â 
physician	 Â clinics	 Â that	 Â have	 Â an	 Â onsite	 Â pharmacy	 Â with	 Â a	 Â licensed	 Â pharmacist,	 Â dedicated	 Â space	 Â 
with	 Â  adequate	 Â  storage,	 Â  refrigeration	 Â  and	 Â  record	 Â  keeping	 Â  were	 Â  allowed	 Â  to	 Â  continue	 Â  to	 Â 
dispense	 Â  drugs.	 Â  Second,	 Â  clinics	 Â  without	 Â  an	 Â  onsite	 Â  pharmacy	 Â  were	 Â  allowed	 Â  to	 Â  continue	 Â  to	 Â 
dispense	 Â  drugs	 Â  to	 Â  children	 Â  and	 Â  the	 Â  elderly	 Â  for	 Â  acute	 Â  medical	 Â  conditions	 Â  for	 Â  which	 Â  quick	 Â 
dispensing	 Â of	 Â drugs	 Â was	 Â deemed	 Â important.	 Â 	 Â 



                                                                            6
                                                                                                                                                                                                                                                                  	 Â 


          The	 Â separating	 Â policy	 Â was	 Â rolled	 Â out	 Â across	 Â villages	 Â over	 Â the	 Â course	 Â of	 Â several	 Â years,	 Â 
beginning	 Â in	 Â March	 Â 1997.	 Â Before	 Â enforcing	 Â the	 Â policy	 Â in	 Â a	 Â village,	 Â the	 Â NHIB	 Â had	 Â to	 Â ascertain	 Â 
that	 Â  there	 Â  were	 Â  sufficient	 Â  numbers	 Â  of	 Â  independent	 Â  pharmacies	 Â  where	 Â  patients	 Â  could	 Â  fill	 Â 
their	 Â prescriptions.	 Â Villages	 Â became	 Â subject	 Â to	 Â the	 Â policy	 Â as	 Â soon	 Â as	 Â the	 Â NHIB	 Â determined	 Â 
there	 Â  was	 Â  at	 Â  least	 Â  1	 Â  independent	 Â  pharmacy	 Â  for	 Â  every	 Â  500	 Â  residents.	 Â  There	 Â  was	 Â  a	 Â  sharp	 Â 
increase	 Â  in	 Â  pharmacists	 Â  following	 Â  the	 Â  implementation	 Â  of	 Â  the	 Â  policy.	 Â  Between	 Â  1997	 Â  and	 Â 
2001	 Â  the	 Â  number	 Â  of	 Â  licensed	 Â  pharmacists	 Â  grew	 Â  from	 Â  23,892	 Â  t	 Â  over	 Â  40,000,	 Â  and	 Â  pharmacist	 Â 
monthly	 Â salaries	 Â jumped	 Â dramatically	 Â from	 Â an	 Â average	 Â of	 Â US$	 Â 625	 Â to	 Â US$	 Â 1870.	 Â 
          There	 Â was	 Â concern	 Â that	 Â physicians	 Â tried	 Â to	 Â get	 Â around	 Â the	 Â separating	 Â policy	 Â through	 Â 
â€œgateway	 Â pharmacies,â€	 Â which	 Â are	 Â legally	 Â independent	 Â pharmacies	 Â registered	 Â in	 Â the	 Â name	 Â of	 Â 
the	 Â  pharmacist	 Â  but	 Â  in	 Â  reality	 Â  owned	 Â  by	 Â  clinic	 Â  physicians.	 Â  Although	 Â  the	 Â  true	 Â  status	 Â  of	 Â 
independent	 Â pharmacies	 Â is	 Â unobservable,	 Â Lee	 Â (2007)	 Â defined	 Â gateway	 Â pharmacies	 Â as	 Â those	 Â 
for	 Â whom	 Â 70%	 Â of	 Â their	 Â prescriptions	 Â came	 Â from	 Â a	 Â single	 Â physician	 Â group.	 Â He	 Â estimated	 Â that	 Â 
only	 Â 3.6%	 Â of	 Â clinics	 Â used	 Â gateway	 Â pharmacies	 Â in	 Â 2000,	 Â the	 Â end	 Â of	 Â our	 Â study	 Â period.	 Â 	 Â 

4. Data	 Â                                                                       	 Â 

                     Our	 Â  data	 Â  is	 Â  a	 Â  0.2%	 Â  random	 Â  sample	 Â  of	 Â  all	 Â  ambulatory	 Â  care	 Â  claims	 Â  from	 Â  1997	 Â  through	 Â 
2000.5	 Â While	 Â  the	 Â  separating	 Â  policy	 Â  was	 Â  implemented	 Â  at	 Â  the	 Â  village	 Â  level,	 Â  the	 Â  claims	 Â  data	 Â 
provide	 Â  geographic	 Â  identification	 Â  at	 Â  the	 Â  township	 Â  level;	 Â  each	 Â  township	 Â  includes	 Â  multiple	 Â 
villages.	 Â  We	 Â  drop	 Â  data	 Â  from	 Â  townships	 Â  with	 Â  mixed	 Â  implementation	 Â  dates,	 Â  approximately	 Â 
25%	 Â  of	 Â  the	 Â  sample.	 Â  While	 Â  Townships	 Â  are	 Â  more	 Â  aggregate	 Â  than	 Â  villages	 Â  they	 Â  are	 Â 
substantially	 Â smaller	 Â than	 Â municipalities.	 Â Taiwan	 Â has	 Â 24	 Â municipalities	 Â and	 Â 194	 Â Townships.	 Â 	 Â 
          The	 Â  unit	 Â  of	 Â  observation	 Â  is	 Â  the	 Â  outpatient	 Â  visit.	 Â  	 Â  Available	 Â  information	 Â  in	 Â  the	 Â  dataset	 Â 
includes	 Â  use	 Â  of	 Â  and	 Â  expenditures	 Â  for	 Â  physician	 Â  and	 Â  complementary	 Â  medical	 Â  services	 Â 
associated	 Â  with	 Â  those	 Â  office	 Â  visits,	 Â  regardless	 Â  of	 Â  where	 Â  those	 Â  services	 Â  were	 Â  provided.In	 Â 
Table	 Â  1	 Â  we	 Â  provide	 Â  baseline	 Â  descriptive	 Â  statistics	 Â  disaggregated	 Â  by	 Â  a	 Â  clinicâ€™s	 Â  integration	 Â 
status	 Â at	 Â baseline	 Â â€“	 Â i.e.	 Â whether	 Â they	 Â had	 Â a	 Â pharmacy	 Â inside	 Â the	 Â clinic.	 Â At	 Â baseline,	 Â prior	 Â to	 Â 
the	 Â  separating	 Â  policy,	 Â  35%	 Â  of	 Â  clinics	 Â  had	 Â  an	 Â  onsite	 Â  pharmacy	 Â  (Table	 Â  1,	 Â  Panel	 Â  B).	 Â  Consistent	 Â 

          	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
5
 	 Â We	 Â limit	 Â our	 Â study	 Â to	 Â the	 Â period	 Â ending	 Â on	 Â December	 Â 31,	 Â 2000	 Â as	 Â the	 Â separating	 Â policy	 Â was	 Â implemented	 Â in	 Â 
most	 Â of	 Â Taiwan	 Â by	 Â the	 Â end	 Â of	 Â 2000	 Â and	 Â the	 Â NHIB	 Â changed	 Â physician	 Â payment	 Â from	 Â fee	 Â for	 Â service	 Â to	 Â Global	 Â 
Budgets	 Â in	 Â 2001.	 Â 


                                                                                                                                                                                                                                                              7
                                                                                                                                                             	 Â 


with	 Â  our	 Â  conceptual	 Â  framework,	 Â  the	 Â  integrated	 Â  clinics	 Â  were	 Â  substantially	 Â  larger	 Â  than	 Â  the	 Â 
non-Â­â€integrated	 Â  clinics	 Â  in	 Â  terms	 Â  scale	 Â  (visits	 Â  and	 Â  revenues).	 Â  While	 Â  integrated	 Â  clinics	 Â  are	 Â 
larger	 Â than	 Â non-Â­â€integrated	 Â clinics,	 Â there	 Â are	 Â no	 Â real	 Â differences	 Â in	 Â the	 Â types	 Â of	 Â patients	 Â that	 Â 
they	 Â attract	 Â or	 Â in	 Â they	 Â way	 Â in	 Â which	 Â they	 Â treat	 Â those	 Â patients.	 Â 	 Â 	 Â 

5. Policy	 Â Impact	 Â 

         In	 Â  this	 Â  section	 Â  we	 Â  estimate	 Â  the	 Â  reduced-Â­â€form	 Â  impact	 Â  of	 Â  the	 Â  separating	 Â  policy	 Â  on	 Â 
clinics	 Â  that	 Â  did	 Â  not	 Â  have	 Â  a	 Â  pharmacy	 Â  onsite	 Â  at	 Â  baseline.	 Â  The	 Â  effect	 Â  is	 Â  reduced	 Â  form	 Â  in	 Â  the	 Â 
sense	 Â  that	 Â  it	 Â  is	 Â  an	 Â  average	 Â  of	 Â  the	 Â  effects	 Â  for	 Â  clinics	 Â  subject	 Â  to	 Â  the	 Â  policy	 Â  at	 Â  baseline	 Â 
regardless	 Â of	 Â their	 Â decision	 Â to	 Â integrate	 Â in	 Â reaction	 Â to	 Â the	 Â policy.	 Â 	 Â 

      5.1.              	 Â Event	 Â History	 Â Analysis	 Â 

          Figures	 Â  1	 Â  and	 Â  2	 Â  plot	 Â  the	 Â  share	 Â  of	 Â  visits	 Â  that	 Â  receive	 Â  drug	 Â  prescriptions	 Â  and	 Â  the	 Â 
average	 Â  drug	 Â  expenditure	 Â  per	 Â  visit	 Â  conditional	 Â  on	 Â  positive	 Â  expenditures	 Â  over	 Â  time	 Â  for	 Â  3	 Â 
groups:	 Â (1)	 Â clinics	 Â that	 Â never	 Â had	 Â an	 Â onsite	 Â pharmacy	 Â (never)	 Â and	 Â therefore	 Â were	 Â subject	 Â to	 Â 
the	 Â separating	 Â policy,	 Â (2)	 Â those	 Â that	 Â did	 Â not	 Â have	 Â an	 Â onsite	 Â pharmacy	 Â prior	 Â to	 Â the	 Â policy	 Â but	 Â 
added	 Â one	 Â post	 Â policy	 Â (switchers)	 Â and	 Â thus	 Â became	 Â exempt	 Â form	 Â the	 Â policy,	 Â and	 Â (3)	 Â those	 Â 
that	 Â  had	 Â  an	 Â  onsite	 Â  pharmacy	 Â  prior	 Â  to	 Â  the	 Â  implementation	 Â  of	 Â  the	 Â  policy	 Â  (always)	 Â  and	 Â 
therefore	 Â were	 Â always	 Â exempt	 Â from	 Â the	 Â policy.	 Â The	 Â horizontal	 Â axis	 Â is	 Â centered	 Â at	 Â time	 Â zero,	 Â 
which	 Â  is	 Â  the	 Â  month	 Â  in	 Â  which	 Â  the	 Â  separating	 Â  policy	 Â  became	 Â  effective	 Â  in	 Â  the	 Â  township	 Â  in	 Â 
which	 Â  the	 Â  clinic	 Â  is	 Â  located.	 Â  Observations	 Â  to	 Â  the	 Â  right	 Â  of	 Â  zero	 Â  refer	 Â  to	 Â  months	 Â  post	 Â 
implementation,	 Â and	 Â observations	 Â to	 Â the	 Â left	 Â refer	 Â to	 Â months	 Â prior	 Â to	 Â implementation.	 Â 	 Â 
          Prior	 Â  to	 Â  the	 Â  implementation	 Â  of	 Â  the	 Â  separating	 Â  policy,	 Â  the	 Â  levels	 Â  and	 Â  trends	 Â  of	 Â  drug	 Â 
prescriptions	 Â  are	 Â  similar	 Â  for	 Â  all	 Â  3	 Â  types	 Â  of	 Â  clinics.	 Â  However,	 Â  after	 Â  implementation,	 Â  drug	 Â 
prescriptions	 Â  fell	 Â  in	 Â  the	 Â  never	 Â  clinics	 Â  who	 Â  were	 Â  subject	 Â  to	 Â  the	 Â  policy.	 Â  On	 Â  the	 Â  other	 Â  hand,	 Â 
drug	 Â  prescriptions	 Â  in	 Â  the	 Â  always	 Â  and	 Â  switcher	 Â  clinics	 Â  who	 Â  were	 Â  exempt	 Â  from	 Â  the	 Â  policy	 Â 
continued	 Â on	 Â trend	 Â after	 Â the	 Â implementation	 Â of	 Â the	 Â policy.	 Â 

      5.2. Identification	 Â Strategy	 Â 

         We	 Â use	 Â a	 Â difference-Â­â€in-Â­â€differences	 Â approach	 Â that	 Â compares	 Â the	 Â change	 Â in	 Â outcomes	 Â in	 Â 
the	 Â treatment	 Â group	 Â to	 Â the	 Â change	 Â in	 Â outcomes	 Â in	 Â a	 Â comparison	 Â group.	 Â The	 Â change	 Â in	 Â the	 Â 


                                                                                   8
                                                                                                                                                                 	 Â 


comparison	 Â  group	 Â  is	 Â  an	 Â  estimate	 Â  of	 Â  the	 Â  true	 Â  counterfactual	 Â  â€“	 Â  that	 Â  is,	 Â  what	 Â  would	 Â  have	 Â 
happened	 Â to	 Â the	 Â treatment	 Â group	 Â if	 Â there	 Â were	 Â no	 Â intervention.	 Â The	 Â strategy	 Â controls	 Â for	 Â 
time-Â­â€invariant	 Â characteristics	 Â at	 Â the	 Â physician	 Â level	 Â as	 Â well	 Â as	 Â time-Â­â€varying	 Â factors	 Â common	 Â 
to	 Â  both	 Â  comparison	 Â  and	 Â  treatment	 Â  physicians	 Â  at	 Â  the	 Â  local	 Â  municipality	 Â  level,	 Â  and	 Â  for	 Â 
heterogeneity	 Â in	 Â patient	 Â demographic	 Â and	 Â epidemiological	 Â case-Â­â€mix.	 Â 	 Â 
       Our	 Â comparison	 Â group	 Â is	 Â the	 Â set	 Â of	 Â clinics	 Â that	 Â had	 Â onsite	 Â pharmacies	 Â at	 Â baseline	 Â and	 Â 
therefore	 Â  were	 Â  not	 Â  subject	 Â  to	 Â  the	 Â  separating	 Â  policy.	 Â  The	 Â  advantage	 Â  of	 Â  this	 Â  comparison	 Â 
group	 Â  is	 Â  that	 Â  they	 Â  are	 Â  located	 Â  in	 Â  the	 Â  same	 Â  municipalities	 Â  as	 Â  the	 Â  treatment	 Â  group.	 Â  This	 Â 
allows	 Â  us	 Â  to	 Â  control	 Â  for	 Â  time-Â­â€varying	 Â  factors	 Â  that	 Â  may	 Â  have	 Â  been	 Â  introduced	 Â 
contemporaneously	 Â  at	 Â  the	 Â  municipality	 Â  level	 Â  with	 Â  the	 Â  implementation	 Â  of	 Â  the	 Â  policy,	 Â  but	 Â 
allows	 Â  time-Â­â€varying	 Â  shocks	 Â  to	 Â  have	 Â  different	 Â  impacts	 Â  across	 Â  municipalities.	 Â  Examples	 Â 
include	 Â new	 Â local	 Â health	 Â policies,	 Â differential	 Â economic	 Â growth,	 Â and	 Â differing	 Â changes	 Â in	 Â the	 Â 
local	 Â epidemiological	 Â environment.	 Â 	 Â 
          We	 Â estimate	 Â the	 Â following	 Â specification:	 Â 

                                  ğ‘¦!"#$% = ğ›¼! + ğ›¾!" +                        ! ğ›¿! ğ‘¥!"   + ğ›½ 1 âˆ’ ğ¼!,!"# ğ‘‡!" + ğœ€!"#$%                                         (2)
where	 Â 	 Â 
      â€¢     yijkmt	 Â  is	 Â  the	 Â  dependent	 Â  variable	 Â  for	 Â  patient	 Â  i	 Â  who	 Â  is	 Â  treated	 Â  by	 Â  physician	 Â  j	 Â  living	 Â  in	 Â 
            township	 Â k	 Â and	 Â municipality	 Â m	 Â in	 Â period	 Â t;	 Â 	 Â 
      â€¢     Î±j	 Â is	 Â a	 Â fixed	 Â effect	 Â for	 Â physician	 Â j;	 Â 	 Â 
      â€¢     Î³mt	 Â is	 Â a	 Â fixed	 Â effect	 Â for	 Â municipality	 Â m	 Â in	 Â time	 Â period	 Â t;	 Â 	 Â 
      â€¢     xit	 Â  is	 Â  a	 Â  vector	 Â  of	 Â  individual	 Â  patient	 Â  characteristics	 Â  including	 Â  age,	 Â  sex	 Â  and	 Â  65	 Â 
            indicators	 Â of	 Â the	 Â patientâ€™s	 Â primary	 Â illness	 Â diagnosis;	 Â 	 Â 
      â€¢     Ij,pre	 Â =	 Â 1	 Â if	 Â clinic	 Â j	 Â had	 Â an	 Â onsite	 Â pharmacy	 Â prior	 Â to	 Â the	 Â implementation	 Â of	 Â the	 Â policy;	 Â 
      â€¢     Tkt	 Â =	 Â 1	 Â if	 Â the	 Â separating	 Â policy	 Â is	 Â in	 Â force	 Â in	 Â township	 Â k	 Â in	 Â period	 Â t;	 Â and	 Â 
      â€¢     Îµijkmt	 Â is	 Â a	 Â zero	 Â mean	 Â random	 Â error.	 Â 	 Â 
      The	 Â coefficient	 Â Î²	 Â is	 Â the	 Â difference-Â­â€in-Â­â€difference	 Â estimate	 Â of	 Â the	 Â impact	 Â of	 Â the	 Â policy	 Â on	 Â 
drug	 Â  expenditures	 Â  and	 Â  diagnostic	 Â  expenditures.	 Â  The	 Â  physician	 Â  fixed-Â­â€effects	 Â  control	 Â  for	 Â 
unobserved	 Â  heterogeneity	 Â  between	 Â  physicians.	 Â  The	 Â  65-Â­â€illness	 Â  indicators	 Â  combined	 Â  with	 Â 
patient	 Â  age	 Â  and	 Â  sex	 Â  control	 Â  for	 Â  heterogeneity	 Â  in	 Â  patient	 Â  case-Â­â€mix.	 Â  And	 Â  the	 Â  municipality	 Â 
specific	 Â time	 Â fixed-Â­â€effects	 Â control	 Â for	 Â factors	 Â that	 Â change	 Â over	 Â time	 Â but	 Â are	 Â common	 Â to	 Â both	 Â 


                                                                                         9
                                                                                                                                                                                                                                                                   	 Â 


treatment	 Â  and	 Â  comparison	 Â  groups	 Â  within	 Â  each	 Â  municipality.	 Â  The	 Â  standard	 Â  errors	 Â  are	 Â 
clustered	 Â at	 Â the	 Â township	 Â level.	 Â 

      5.3.                                                                       	 Â Results	 Â 	 Â 

              The	 Â  results,	 Â  presented	 Â  in	 Â  Panel	 Â  A	 Â  of	 Â  Table	 Â  2,	 Â  are	 Â  consistent	 Â  with	 Â  our	 Â  theoretical	 Â 
predictions.	 Â  The	 Â  separating	 Â  policy	 Â  reduced	 Â  the	 Â  likelihood	 Â  of	 Â  prescription	 Â  by	 Â  1.4	 Â  percentage	 Â 
points	 Â  and	 Â  drug	 Â  expenditures	 Â  conditional	 Â  on	 Â  a	 Â  prescription	 Â  by	 Â  3.8%.	 Â  These	 Â  translate	 Â  into	 Â  a	 Â 
reduction	 Â  in	 Â  total	 Â  drugs	 Â  expenditures	 Â  of	 Â  5.2%	 Â  among	 Â  clinics	 Â  that	 Â  did	 Â  not	 Â  have	 Â  an	 Â  onsite	 Â 
pharmacy	 Â  at	 Â  baseline.6	 Â 	 Â  Physicians	 Â  did	 Â  compensate	 Â  by	 Â  slightly	 Â  increasing	 Â  the	 Â  share	 Â  of	 Â 
patients	 Â that	 Â had	 Â diagnostic	 Â tests	 Â but	 Â there	 Â was	 Â no	 Â effect	 Â on	 Â physician	 Â services.	 Â Overall,	 Â the	 Â 
policy	 Â reduced	 Â total	 Â costs	 Â (drug	 Â plus	 Â diagnostic	 Â plus	 Â physician	 Â services)	 Â by	 Â 1.3%	 Â in	 Â clinics	 Â 
not	 Â integrated	 Â at	 Â baseline.	 Â However,	 Â the	 Â policy	 Â was	 Â binding	 Â only	 Â for	 Â clinics	 Â that	 Â did	 Â had	 Â an	 Â 
onsite	 Â pharmacy,	 Â which	 Â at	 Â baseline	 Â treated	 Â 40%	 Â of	 Â patients.	 Â Hence,	 Â the	 Â overall	 Â impact	 Â on	 Â 
total	 Â drug	 Â expenditures	 Â was	 Â only	 Â 1.7%	 Â and	 Â on	 Â total	 Â expenditures	 Â was	 Â a	 Â reduction	 Â of	 Â 0.5%.	 Â 
          Our	 Â  results	 Â  are	 Â  substantially	 Â  smaller	 Â  than	 Â  those	 Â  of	 Â  Chou	 Â  et	 Â  al	 Â  (2003)	 Â  who	 Â  report	 Â  a	 Â 
16%	 Â reduction	 Â in	 Â the	 Â probability	 Â of	 Â prescription	 Â and	 Â a	 Â 12%	 Â fall	 Â in	 Â drug	 Â costs	 Â conditional	 Â on	 Â 
a	 Â  prescription	 Â  associated	 Â  with	 Â  the	 Â  initial	 Â  implementation	 Â  of	 Â  the	 Â  separating	 Â  policy.	 Â  They	 Â 
compared	 Â the	 Â average	 Â change	 Â in	 Â drug	 Â expenditures	 Â in	 Â two	 Â municipalities	 Â nine	 Â months	 Â after	 Â 
the	 Â policy	 Â was	 Â implemented	 Â compared	 Â to	 Â the	 Â average	 Â change	 Â in	 Â two	 Â other	 Â cities	 Â that	 Â had	 Â 
not	 Â  yet	 Â  implemented.	 Â  Some	 Â  of	 Â  the	 Â  reasons	 Â  for	 Â  these	 Â  differences	 Â  could	 Â  due	 Â  to:	 Â  (1)	 Â  we	 Â 
examine	 Â  the	 Â  impact	 Â  of	 Â  the	 Â  policy	 Â  nationwide	 Â  in	 Â  all	 Â  24	 Â  municipalities	 Â  and	 Â  for	 Â  a	 Â  substantially	 Â 
longer	 Â period	 Â (3	 Â years);	 Â (2)	 Â the	 Â short	 Â recall	 Â period	 Â in	 Â the	 Â Chou	 Â et	 Â al	 Â analysis	 Â may	 Â not	 Â have	 Â 
long	 Â  enough	 Â  to	 Â  fully	 Â  capture	 Â  the	 Â  extent	 Â  to	 Â  which	 Â  clinics	 Â  integrated	 Â  pharmacies	 Â  onsite	 Â  to	 Â 
circumvent	 Â the	 Â policy,	 Â which	 Â would	 Â tend	 Â to	 Â lower	 Â the	 Â estimates;	 Â (3)	 Â we	 Â employ	 Â a	 Â visit	 Â level	 Â 
analysis	 Â  that	 Â  additionally	 Â  controls	 Â  for	 Â  physician	 Â  fixed	 Â  effects,	 Â  patient	 Â  and	 Â  illness	 Â 
characteristics,	 Â and	 Â time-Â­â€varying	 Â factors	 Â at	 Â the	 Â municipality	 Â level;	 Â and	 Â (4)	 Â we	 Â also	 Â confirm	 Â 
the	 Â validity	 Â of	 Â our	 Â comparison	 Â groups	 Â using	 Â a	 Â number	 Â of	 Â robustness	 Â and	 Â specification	 Â tests.	 Â 

          	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
6
 	 Â We	 Â calculate	 Â %Î”	 Â in	 Â expenditures	 Â as	 Â follows.	 Â Note	 Â that	 Â ğ¸ ğ¸ğ‘¥ğ‘ = ğ¸ ğ¸ğ‘¥ğ‘ ğ¸ğ‘¥ğ‘ > 0 âˆ— ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 . Â Totally	 Â 
differentiating	 Â and	 Â rearranging	 Â terms	 Â gives	 Â us	 Â  âˆ†ğ¸ğ‘¥ğ‘ ğ¸ğ‘¥ğ‘ âˆ— 100 = âˆ†ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 +
âˆ†ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 âˆ— 100.	 Â The	 Â terms	 Â âˆ†ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 	 Â and	 Â âˆ†ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ >
0 	 Â are	 Â estimated	 Â coefficients	 Â and	 Â ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 	 Â is	 Â estimated	 Â as	 Â the	 Â baseline	 Â mean	 Â for	 Â the	 Â clinics	 Â that	 Â did	 Â not	 Â 
integrate	 Â from	 Â Table	 Â 1.	 Â 


                                                                                                                                                                                                                                                              10
                                                                                                                                                                                                                                                                      	 Â 


         5.4.                                                                       	 Â Control	 Â Group	 Â Validity	 Â 

                        5.4.1. Baseline	 Â Balance	 Â of	 Â Treatment	 Â and	 Â Comparison	 Â Groups	 Â 

                 We	 Â first	 Â show	 Â that	 Â the	 Â treatment	 Â and	 Â comparison	 Â sample	 Â is	 Â balanced	 Â in	 Â 1997	 Â prior	 Â to	 Â 
the	 Â  implementation	 Â  of	 Â  the	 Â  policy.	 Â  	 Â  This	 Â  rules	 Â  out	 Â  Ashefelter	 Â  dip	 Â  type	 Â  explanations	 Â  for	 Â 
treatment	 Â  effects	 Â  in	 Â  the	 Â  difference	 Â  in	 Â  difference	 Â  estimates.	 Â  Panel	 Â  A	 Â  in	 Â  Table	 Â  1	 Â  compares	 Â  the	 Â 
means	 Â  of	 Â  patient	 Â  characteristics	 Â  and	 Â  treatment	 Â  patterns	 Â  of	 Â  the	 Â  treatment	 Â  clinics	 Â  (Not	 Â 
Integrated)	 Â  and	 Â  comparison	 Â  clinics	 Â  (Integrated).	 Â  	 Â  Both	 Â  treatment	 Â  and	 Â  comparison	 Â  clinics	 Â 
attracted	 Â  the	 Â  same	 Â  type	 Â  of	 Â  patients	 Â  and	 Â  provided	 Â  those	 Â  patterns	 Â  with	 Â  the	 Â  same	 Â  type	 Â  of	 Â  care	 Â 
in	 Â  terms	 Â  of	 Â  drug	 Â  prescriptions	 Â  and	 Â  diagnostic	 Â  tests.	 Â  There	 Â  are	 Â  no	 Â  statistically	 Â  significant	 Â 
differences	 Â in	 Â the	 Â means	 Â of	 Â 12	 Â out	 Â of	 Â the	 Â 13	 Â patient	 Â level	 Â variables	 Â in	 Â Table	 Â 1.	 Â Specifically,	 Â 
we	 Â  find	 Â  no	 Â  differences	 Â  in	 Â  patient	 Â  sex	 Â  and	 Â  or	 Â  in	 Â  medical	 Â  reason	 Â  for	 Â  the	 Â  visit.	 Â  Slightly	 Â  over	 Â 
40%	 Â of	 Â their	 Â office	 Â visits	 Â to	 Â both	 Â types	 Â of	 Â clinics	 Â are	 Â for	 Â a	 Â respiratory	 Â infection.	 Â Physicians	 Â 
in	 Â both	 Â types	 Â of	 Â clinics	 Â preform	 Â diagnostics	 Â test	 Â on	 Â about	 Â 3%	 Â of	 Â patients	 Â and	 Â spent	 Â about	 Â 
the	 Â  same	 Â  amount	 Â  on	 Â  those	 Â  tests.	 Â  Physicians	 Â  in	 Â  both	 Â  types	 Â  of	 Â  clinics	 Â  also	 Â  prescribed	 Â 
medications	 Â to	 Â almost	 Â all	 Â patients,	 Â prescribed	 Â identical	 Â classes	 Â of	 Â medications	 Â (primarily	 Â of	 Â 
antacids,	 Â  anti-Â­â€inflammatory	 Â  agents,	 Â  antihistamines,	 Â  and	 Â  other	 Â  palliative	 Â  medications	 Â 
associated	 Â with	 Â the	 Â common	 Â cold	 Â or	 Â upper	 Â respiratory	 Â infections),	 Â and	 Â prescribed	 Â the	 Â same	 Â 
amount	 Â  in	 Â  terms	 Â  of	 Â  expenditures	 Â  on	 Â  drugs.	 Â  The	 Â  one	 Â  difference	 Â  in	 Â  that	 Â  slightly	 Â  younger	 Â 
patients	 Â seem	 Â to	 Â visit	 Â integrated	 Â clinics.7	 Â 	 Â 

                        5.4.2. Pre-Â­â€intervention	 Â Trends	 Â 	 Â 

                 The	 Â  key	 Â  assumption	 Â  underlying	 Â  the	 Â  causal	 Â  interpretation	 Â  in	 Â  our	 Â  difference	 Â  in	 Â 
differences	 Â model	 Â is	 Â that	 Â the	 Â change	 Â in	 Â the	 Â comparison	 Â group	 Â is	 Â an	 Â unbiased	 Â estimate	 Â of	 Â the	 Â 
counterfactual	 Â â€“	 Â i.e.	 Â what	 Â would	 Â have	 Â been	 Â the	 Â change	 Â in	 Â the	 Â treatment	 Â group	 Â without	 Â the	 Â 
separating	 Â  policy.	 Â  While	 Â  we	 Â  cannot	 Â  directly	 Â  test	 Â  this	 Â  assumption,	 Â  we	 Â  did	 Â  employ	 Â  the	 Â 
Heckman-Â­â€Hotz	 Â  test	 Â  that	 Â  asks	 Â  whether	 Â  the	 Â  pre-Â­â€intervention	 Â  trends	 Â  of	 Â  the	 Â  treatment	 Â  group	 Â 
are	 Â  different	 Â  from	 Â  those	 Â  of	 Â  the	 Â  comparison	 Â  group.	 Â  If	 Â  the	 Â  pre-Â­â€intervention	 Â  trends	 Â  are	 Â  not	 Â 
different,	 Â  there	 Â  would	 Â  be	 Â  no	 Â  reason	 Â  to	 Â  assume	 Â  that	 Â  they	 Â  would	 Â  be	 Â  different	 Â  in	 Â  the	 Â  post	 Â 
period	 Â without	 Â the	 Â intervention.	 Â 	 Â 

             	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
7
    	 Â Recall	 Â that	 Â we	 Â explicitly	 Â control	 Â for	 Â patient	 Â age	 Â along	 Â with	 Â gender	 Â and	 Â illness	 Â diagnosis	 Â in	 Â the	 Â models.	 Â 


                                                                                                                                                                                                                                                                 11
                                                                                                                                                                                   	 Â 


           We	 Â  implement	 Â  the	 Â  test	 Â  by	 Â  dropping	 Â  all	 Â  post-Â­â€policy	 Â  observations	 Â  from	 Â  our	 Â  sample,	 Â 
and	 Â running	 Â the	 Â following	 Â model:	 Â 

                          ğ‘¦!"#$% = ğ›¼! + ğ›¾!" +                   ! ğ›¿! ğ‘¥!"      +   ! ğœ†!     1 âˆ’ ğ¼!,!"# ğ‘™! ğ‘‡ğ‘Ÿğ‘’ğ‘›ğ‘‘! + ğœ€!"#$% 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â (3)

where	 Â lm	 Â =	 Â 1	 Â if	 Â the	 Â clinic	 Â is	 Â located	 Â in	 Â municipality	 Â m,	 Â Trendt	 Â is	 Â a	 Â continuous	 Â time	 Â variable	 Â 
indicating	 Â quarter,	 Â and	 Â all	 Â other	 Â variables	 Â are	 Â as	 Â defined	 Â for	 Â equation	 Â (2).	 Â 	 Â 
            The	 Â coefficients	 Â of	 Â interest	 Â are	 Â the	 Â  Î»mâ€™s	 Â on	 Â the	 Â interaction	 Â terms	 Â of	 Â the	 Â municipality	 Â 
dummies,	 Â  future	 Â  treatment	 Â  dummies	 Â  and	 Â  the	 Â  time	 Â  trend.	 Â  Note	 Â  that	 Â  we	 Â  test	 Â  if	 Â  the	 Â  pre-Â­â€
intervention	 Â  trends	 Â  are	 Â  equal	 Â  for	 Â  each	 Â  municipality	 Â  separately	 Â  and	 Â  jointly.	 Â  If	 Â  these	 Â  are	 Â 
jointly	 Â zero,	 Â then	 Â we	 Â reject	 Â the	 Â hypothesis	 Â that	 Â the	 Â pre-Â­â€intervention	 Â trends	 Â are	 Â different	 Â for	 Â 
the	 Â treatment	 Â and	 Â comparison	 Â groups.	 Â 	 Â                	 Â 
	 Â         We	 Â  estimate	 Â  equation	 Â  (3)	 Â  for	 Â  each	 Â  of	 Â  the	 Â  dependent	 Â  variables.	 Â Almost	 Â  all	 Â of	 Â  the	 Â  Î»mâ€™s	 Â 
(84	 Â out	 Â 90)	 Â are	 Â not	 Â significantly	 Â different	 Â that	 Â zero	 Â and	 Â the	 Â F-Â­â€statistics	 Â for	 Â the	 Â hypothesis	 Â 
that	 Â  all	 Â  of	 Â  the	 Â  coefficient	 Â  interaction	 Â  terms	 Â  are	 Â  jointly	 Â  for	 Â  each	 Â  outcome	 Â  zero	 Â  cannot	 Â  be	 Â 
rejected	 Â  at	 Â  conventional	 Â  significance	 Â  levels	 Â  for	 Â  each	 Â  of	 Â  the	 Â  five	 Â  dependent	 Â  variables	 Â 
(Appendix	 Â Table	 Â A1).	 Â 

       5.5. 	 Â 	 Â Robustness	 Â Tests	 Â 

            5.5.1. Alternative	 Â Identification	 Â Strategy	 Â 

        Another	 Â source	 Â of	 Â variation	 Â that	 Â can	 Â be	 Â used	 Â to	 Â identify	 Â  causal	 Â impacts	 Â comes	 Â from	 Â the	 Â 
fact	 Â  that	 Â  the	 Â  policy	 Â  was	 Â  phased	 Â  in	 Â  geographically	 Â  over	 Â  time.	 Â  In	 Â  this	 Â  case	 Â  the	 Â  treatment	 Â 
group	 Â consists	 Â of	 Â clinics	 Â located	 Â in	 Â the	 Â municipalities	 Â that	 Â were	 Â early	 Â adopters	 Â of	 Â the	 Â policy	 Â 
and	 Â  the	 Â  comparison	 Â  group	 Â  consist	 Â  of	 Â  those	 Â  located	 Â  in	 Â  late	 Â  adopter	 Â  counties.	 Â  In	 Â  this	 Â  case	 Â  the	 Â 
treatment	 Â group	 Â consists	 Â of	 Â clinics	 Â located	 Â in	 Â the	 Â townships	 Â that	 Â were	 Â early	 Â adopters	 Â of	 Â the	 Â 
policy	 Â and	 Â the	 Â comparison	 Â group	 Â consist	 Â of	 Â those	 Â located	 Â in	 Â late	 Â adopter	 Â townships.	 Â 	 Â 
        However,	 Â this	 Â strategy	 Â has	 Â two	 Â limitations.	 Â First,	 Â it	 Â can	 Â only	 Â controls	 Â for	 Â time	 Â varying	 Â 
shocks	 Â  that	 Â  are	 Â  common	 Â  across	 Â  all	 Â  treatment	 Â  and	 Â  comparison	 Â  areas,	 Â  but	 Â  not	 Â  for	 Â  time	 Â 
varying	 Â  shocks	 Â  that	 Â  idiosyncratically	 Â  vary	 Â  across	 Â  townships.	 Â  This	 Â  approach	 Â  also	 Â  has	 Â  a	 Â 
smaller	 Â sample	 Â as	 Â it	 Â uses	 Â only	 Â the	 Â clinics	 Â that	 Â did	 Â not	 Â have	 Â an	 Â onsite	 Â pharmacy	 Â at	 Â baseline.	 Â 
        The	 Â specification	 Â is	 Â identical	 Â to	 Â equation	 Â (2),	 Â except	 Â that	 Â the	 Â time	 Â fixed-Â­â€effects	 Â do	 Â not	 Â 
varying	 Â  by	 Â  municipality.	 Â  We	 Â  find	 Â  that	 Â  point	 Â  estimates,	 Â  presented	 Â  in	 Â  Table	 Â  2	 Â  Panel	 Â  B,	 Â  are	 Â 


                                                                                  12
                                                                                                                                                           	 Â 


very	 Â  close	 Â  to	 Â  the	 Â  main	 Â  regression	 Â  results	 Â  in	 Â  Panel	 Â  A	 Â  and	 Â  most	 Â  are	 Â  statistically	 Â  significant.	 Â 
However,	 Â  some	 Â  of	 Â  the	 Â  estimates	 Â  are	 Â  somewhat	 Â  less	 Â  precise	 Â  due	 Â  to	 Â  substantially	 Â  smaller	 Â 
sample	 Â sizes	 Â and	 Â more	 Â limited	 Â variation	 Â for	 Â identification.	 Â 

           5.5.2. Placebo	 Â Test	 Â 

       	 Â  The	 Â  fact	 Â  that	 Â  there	 Â  are	 Â  no	 Â  differences	 Â  in	 Â  the	 Â  pre-Â­â€intervention	 Â  trends	 Â  is	 Â  consistent	 Â 
with	 Â  the	 Â  identifying	 Â  assumptions	 Â  that	 Â  the	 Â  change	 Â  in	 Â  the	 Â  control	 Â  group	 Â  is	 Â  a	 Â  consistent	 Â 
estimate	 Â  of	 Â  the	 Â  counterfactual.	 Â  However,	 Â  we	 Â  still	 Â  cannot	 Â  completely	 Â  rule	 Â  out	 Â  that	 Â  the	 Â 
remote	 Â  possibility	 Â  that	 Â  post	 Â  trends	 Â  may	 Â  have	 Â  diverged	 Â  within	 Â  municipalities	 Â  due	 Â  to	 Â  some	 Â 
unobservable	 Â  post	 Â  policy	 Â  time-Â­â€varying	 Â  factors.	 Â  	 Â  We	 Â  use	 Â  a	 Â  placebo	 Â  test	 Â  to	 Â  rule	 Â  out	 Â  this	 Â 
possibility.	 Â  Specifically,	 Â  we	 Â  estimate	 Â  the	 Â  reduced	 Â  form	 Â  specified	 Â  in	 Â  equation	 Â  (2)	 Â  on	 Â  the	 Â 
sample	 Â  of	 Â  visits	 Â  to	 Â  clinics	 Â  by	 Â  patients	 Â  who	 Â  are	 Â  exempt	 Â  from	 Â  the	 Â  separating	 Â  policy	 Â  i.e.	 Â  the	 Â 
young	 Â  and	 Â  the	 Â  elderly.	 Â  Since	 Â  they	 Â  are	 Â  exempt,	 Â  the	 Â  introduction	 Â  of	 Â  the	 Â  separating	 Â  policy	 Â 
should	 Â have	 Â no	 Â effect	 Â on	 Â drug	 Â and	 Â diagnostic	 Â expenditures	 Â for	 Â these	 Â patients.	 Â The	 Â results	 Â 
are	 Â presented	 Â in	 Â Panel	 Â C	 Â of	 Â Table	 Â 2	 Â and	 Â show	 Â no	 Â effect	 Â of	 Â the	 Â separating	 Â policy.	 Â 

           5.5.3. Patient	 Â Sorting	 Â 

       	 Â  An	 Â alternative	 Â explanation	 Â of	 Â the	 Â results	 Â could	 Â be	 Â patient	 Â sorting	 Â in	 Â response	 Â to	 Â the	 Â 
policy,	 Â  i.e.	 Â  patients	 Â  who	 Â  had	 Â  strong	 Â  preferences	 Â  for	 Â  drugs	 Â  or	 Â  the	 Â  convenience	 Â  of	 Â filling	 Â  their	 Â 
prescriptions	 Â onsite	 Â switched	 Â to	 Â control	 Â facilities	 Â as	 Â a	 Â result	 Â of	 Â the	 Â policy.	 Â 	 Â To	 Â address	 Â this	 Â 
possibility,	 Â we	 Â examined	 Â patient	 Â clinic	 Â switching	 Â behavior	 Â using	 Â a	 Â panel	 Â data	 Â set	 Â of	 Â 200,000	 Â 
individuals.	 Â  Of	 Â  those,	 Â  155,343	 Â  sought	 Â  care	 Â  at	 Â  a	 Â  clinic	 Â  at	 Â  least	 Â  once	 Â  between	 Â  January	 Â  1,	 Â  1997	 Â 
and	 Â December	 Â 31,	 Â 2000.	 Â On	 Â average,	 Â patients	 Â sought	 Â care	 Â six	 Â times	 Â per	 Â year.	 Â Of	 Â those	 Â that	 Â 
patronized	 Â  clinics	 Â  without	 Â  a	 Â  pharmacy	 Â  at	 Â  baseline,	 Â  only	 Â  347	 Â  (0.2%)	 Â  switched	 Â  to	 Â  visit	 Â  a	 Â 
different	 Â clinic	 Â with	 Â a	 Â pharmacy	 Â after	 Â the	 Â policy	 Â was	 Â implemented	 Â in	 Â their	 Â township.	 Â 	 Â 

6. Moral	 Â Hazard	 Â 

          The	 Â moral	 Â hazard	 Â effect	 Â is	 Â the	 Â extra	 Â drug	 Â expenditures	 Â resulting	 Â from	 Â the	 Â incentive	 Â 
to	 Â prescribe	 Â more	 Â drugs	 Â from	 Â physician	 Â ownership	 Â of	 Â pharmacies.	 Â 	 Â The	 Â moral	 Â hazard	 Â effect	 Â 
is	 Â  simply	 Â  the	 Â  difference	 Â  in	 Â  drug	 Â  expenditures	 Â  with	 Â  and	 Â  without	 Â  pharmacy	 Â  ownership.	 Â We	 Â 
identify	 Â  this	 Â  by	 Â  estimating	 Â  the	 Â  effect	 Â  of	 Â  the	 Â  separating	 Â  on	 Â  physician	 Â  treatment	 Â  decisions	 Â 


                                                                                13
                                                                                                                                                               	 Â 


with	 Â and	 Â without	 Â onsite	 Â pharmacies.	 Â This	 Â requires	 Â us	 Â to	 Â estimate	 Â the	 Â effect	 Â of	 Â the	 Â policy	 Â on	 Â 
physician	 Â behavior	 Â explicitly	 Â taking	 Â into	 Â account	 Â the	 Â decision	 Â to	 Â integrate	 Â pharmacies.	 Â 	 Â 

      6.1. 	 Â Integration	 Â 

            A	 Â substantial	 Â number	 Â of	 Â clinics	 Â not	 Â integrated	 Â at	 Â baseline	 Â (38%)	 Â chose	 Â to	 Â integrate	 Â 
after	 Â the	 Â policy	 Â was	 Â implemented	 Â and	 Â the	 Â that	 Â integrated	 Â on	 Â average	 Â had	 Â 68%	 Â more	 Â patient	 Â 
visits	 Â than	 Â those	 Â that	 Â did	 Â not.	 Â Figure	 Â 3	 Â displays	 Â integration	 Â overtime	 Â separately	 Â for	 Â clinics	 Â 
in	 Â  different	 Â  parts	 Â  of	 Â  the	 Â  baseline	 Â  distribution	 Â  of	 Â  patient	 Â  volume.	 Â  The	 Â  probability	 Â  of	 Â 
integration	 Â  is	 Â  effectively	 Â  zero	 Â  up	 Â  until	 Â  the	 Â  separating	 Â  policy	 Â  becomes	 Â  effective	 Â  and	 Â  then	 Â 
increases	 Â  dramatically	 Â  shortly	 Â  thereafter	 Â  with	 Â  substantially	 Â  larger	 Â  increases	 Â  for	 Â  the	 Â 
medium-Â­â€	 Â and	 Â large-Â­â€volume	 Â clinics.	 Â 
            These	 Â  graphical	 Â  results	 Â  are	 Â  confirmed	 Â  in	 Â  a	 Â  difference-Â­â€in-Â­â€difference	 Â  analysis	 Â  of	 Â  the	 Â 
impact	 Â of	 Â the	 Â policy	 Â on	 Â the	 Â integration.	 Â We	 Â estimate	 Â a	 Â clinic	 Â level	 Â version	 Â of	 Â equation	 Â (2)	 Â for	 Â 
integration	 Â  using	 Â  the	 Â  sample	 Â  of	 Â  clinics	 Â  that	 Â  were	 Â  not	 Â  integrated	 Â  at	 Â  baseline.	 Â  Model	 Â  (1)	 Â 
confirms	 Â that	 Â 66%	 Â of	 Â clinics	 Â choice	 Â to	 Â integrate.	 Â Model	 Â (2)	 Â adds	 Â interactions	 Â of	 Â treatment	 Â 
with	 Â  the	 Â  baseline	 Â  quartile	 Â  of	 Â  the	 Â  distribution	 Â  of	 Â  number	 Â  of	 Â  visits.	 Â  The	 Â  results	 Â  show	 Â  that	 Â 
clinics	 Â that	 Â had	 Â larger	 Â volumes	 Â of	 Â patients	 Â at	 Â baseline	 Â were	 Â more	 Â likely	 Â to	 Â integrate.	 Â 

      6.2. Identification	 Â Strategy	 Â 

          We	 Â  employ	 Â  a	 Â  triple	 Â  differences	 Â  strategy	 Â  that	 Â  assumes	 Â  that	 Â  the	 Â  decision	 Â  to	 Â  integrate	 Â 
was	 Â  based	 Â  on	 Â  fixed	 Â  characteristics.	 Â  Specifically,	 Â  we	 Â  compare	 Â  the	 Â  difference-Â­â€in-Â­â€difference	 Â 
estimate	 Â  of	 Â  the	 Â  impact	 Â  of	 Â  the	 Â  policy	 Â  on	 Â  clinics	 Â  that	 Â  did	 Â  not	 Â  integrate	 Â  to	 Â  the	 Â  difference-Â­â€in-Â­â€
difference	 Â  estimate	 Â  of	 Â  the	 Â  impact	 Â  on	 Â  clinics	 Â  that	 Â  did	 Â  integrate.	 Â  The	 Â  first	 Â  double	 Â  difference	 Â 
compares	 Â  the	 Â  change	 Â  in	 Â  outcomes	 Â  of	 Â  those	 Â  that	 Â  did	 Â  not	 Â  integrate	 Â  to	 Â  those	 Â  that	 Â  were	 Â 
integrated	 Â at	 Â baseline	 Â and	 Â the	 Â second	 Â double	 Â difference	 Â compares	 Â the	 Â change	 Â in	 Â those	 Â that	 Â 
did	 Â integrate	 Â to	 Â those	 Â that	 Â were	 Â integrated	 Â at	 Â baseline.	 Â 	 Â 	 Â 
          The	 Â  assumption	 Â  that	 Â  the	 Â  decision	 Â  to	 Â  integrate	 Â  is	 Â  based	 Â  on	 Â  time-Â­â€invariant	 Â 
characteristics	 Â  is	 Â  consistent	 Â  with	 Â  the	 Â  fact	 Â  the	 Â  almost	 Â  all	 Â  clinics	 Â  that	 Â  integrated	 Â  did	 Â  so	 Â 
immediately	 Â  after	 Â  the	 Â  policy	 Â  is	 Â  implemented	 Â  in	 Â  their	 Â  township	 Â  (Figure	 Â  3).	 Â  	 Â  Moreover,	 Â  while	 Â 
patient	 Â volume	 Â is	 Â correlated	 Â with	 Â the	 Â decision	 Â to	 Â integrate	 Â (Table	 Â 3,	 Â Panel	 Â B)	 Â as	 Â predicted	 Â 




                                                                                 14
                                                                                                                                                                                                                                                                                                                                      	 Â 


by	 Â  theory,	 Â  there	 Â  are	 Â  no	 Â  baseline	 Â  differences	 Â  in	 Â  the	 Â  types	 Â  of	 Â  patients	 Â  treated	 Â  or	 Â  in	 Â  the	 Â 
treatment	 Â patterns	 Â between	 Â the	 Â types	 Â of	 Â clinics	 Â (Table	 Â 3,	 Â Panel	 Â A).	 Â 
              	 Â We	 Â adjust	 Â the	 Â specification	 Â in	 Â (2)	 Â to	 Â allow	 Â the	 Â effect	 Â of	 Â the	 Â separating	 Â policy	 Â to	 Â the	 Â 
clinicâ€™s	 Â integration	 Â status	 Â and	 Â integration	 Â interacted	 Â with	 Â treatment:	 Â 

                                  ğ‘¦!"#$% = ğ›¼! + ğ›¾!" +                                                                                                                                                                       ! ğ›¿! ğ‘¥!"                          + ğ›½ 1 âˆ’ ğ¼!,!"# ğ‘‡!" + ğœ™ 1 âˆ’ ğ¼!,!"# ğ‘‡!" ğ¼!" + ğœ€!"#$% 	 Â    	 Â 	 Â 	 Â (4)

where	 Â Ijt	 Â =	 Â 1	 Â if	 Â clinic	 Â j	 Â is	 Â integrated	 Â in	 Â period	 Â t	 Â and	 Â the	 Â rest	 Â are	 Â defined	 Â as	 Â in	 Â equation	 Â (2).	 Â 	 Â 
                     The	 Â  moral	 Â  hazard	 Â  effect	 Â  is	 Â  calculated	 Â  from	 Â  Î²,	 Â  which	 Â  is	 Â  the	 Â  effect	 Â  of	 Â  the	 Â  policy	 Â  on	 Â 
clinics	 Â that	 Â did	 Â not	 Â integrate.	 Â This	 Â is	 Â effect	 Â of	 Â removing	 Â the	 Â incentive	 Â to	 Â overprescribe	 Â drugs	 Â 
by	 Â eliminating	 Â physician	 Â profits	 Â from	 Â drug	 Â sales	 Â through	 Â the	 Â ownership	 Â of	 Â pharmacies.	 Â The	 Â 
effect	 Â of	 Â the	 Â policy	 Â on	 Â clinics	 Â that	 Â integrated	 Â is	 Â Î²	 Â +	 Â Ï†,	 Â which	 Â should	 Â be	 Â zero.	 Â 	 Â 

      6.3. Results	 Â 

              The	 Â  results	 Â  are	 Â  presented	 Â  in	 Â  panel	 Â  A	 Â  of	 Â  Table	 Â  5.	 Â  We	 Â  find	 Â  that	 Â  the	 Â  separating	 Â  policy	 Â 
reduced	 Â  the	 Â  probability	 Â  that	 Â  a	 Â  physician	 Â  working	 Â  in	 Â  a	 Â  non-Â­â€integrated	 Â  clinic	 Â  gave	 Â  a	 Â  drug	 Â 
prescription	 Â  by	 Â  2.1	 Â  percentage	 Â  points	 Â  and	 Â  average	 Â  drug	 Â  expenditures	 Â  conditional	 Â  on	 Â  a	 Â 
prescription	 Â by	 Â 4.9%.	 Â Hence,	 Â the	 Â separating	 Â policy	 Â reduced	 Â drug	 Â expenditure	 Â fell	 Â by	 Â 7.1%	 Â 
for	 Â  this	 Â  group.8	 Â We	 Â  also	 Â  find	 Â  that	 Â  these	 Â  physicians	 Â  slightly	 Â  increased	 Â  diagnostic	 Â  tests.	 Â 
Overall,	 Â the	 Â separating	 Â policy	 Â reduced	 Â total	 Â outpatient	 Â expenditures	 Â by	 Â 1.8%.	 Â As	 Â expected,	 Â 
however,	 Â  the	 Â  separating	 Â  policy	 Â  had	 Â  no	 Â  effect	 Â  on	 Â  physicians	 Â  who	 Â  worked	 Â  in	 Â  clinics	 Â  that	 Â 
integrated	 Â and,	 Â as	 Â a	 Â result,	 Â were	 Â exempt	 Â from	 Â the	 Â separating	 Â policy	 Â -Â­â€-Â­â€	 Â Row	 Â (a)	 Â +	 Â (b).	 Â 
              Our	 Â  results	 Â  imply	 Â  that	 Â  the	 Â  moral	 Â  hazard	 Â  cost	 Â  of	 Â  physicians	 Â  owning	 Â  pharmacies	 Â  is	 Â 
non-Â­â€trivial.	 Â  At	 Â  baseline,	 Â  mean	 Â  drugs	 Â  expenditures	 Â  at	 Â  baseline	 Â  were	 Â  NT$88.91	 Â for	 Â the	 Â group	 Â 
of	 Â  clinics	 Â  that	 Â  did	 Â  not	 Â  integrate.	 Â  A	 Â  7.1%	 Â  reduction	 Â  caused	 Â  by	 Â  the	 Â  separating	 Â  policy	 Â  that	 Â 
eliminated	 Â  the	 Â  incentives	 Â  from	 Â  physician	 Â  ownership	 Â  means	 Â  that	 Â  costs	 Â  were	 Â  reduced	 Â  by	 Â 
NT$6.31	 Â to	 Â NT$82.67,	 Â which	 Â can	 Â be	 Â interpreted	 Â as	 Â the	 Â â€œappropriateâ€	 Â amount	 Â of	 Â drugs	 Â for	 Â 
the	 Â treatment	 Â of	 Â the	 Â patient.	 Â Moral	 Â hazard	 Â increased	 Â expenditures	 Â by	 Â NT$6.01	 Â or	 Â 7.6%.	 Â 	 Â 


          	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
8	 Â We	 Â calculate	 Â %Î”	 Â in	 Â expenditures	 Â as	 Â follows.	 Â Note	 Â that	 Â ğ¸
                                                                              ğ¸ğ‘¥ğ‘ = ğ¸ ğ¸ğ‘¥ğ‘ ğ¸ğ‘¥ğ‘ > 0 ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 . Â Totally	 Â 
differentiating	 Â and	 Â rearranging	 Â terms	 Â gives	 Â us	 Â  âˆ†ğ¸ğ‘¥ğ‘ ğ¸ğ‘¥ğ‘ âˆ— 100 = âˆ†ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 +
âˆ†ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 âˆ— 100.	 Â The	 Â terms	 Â âˆ†ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 ğ¸ ğ¸ğ‘¥ğ‘|ğ¸ğ‘¥ğ‘ > 0 	 Â and	 Â âˆ†ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ >
0 	 Â are	 Â estimated	 Â coefficients	 Â and	 Â ğ‘ƒğ‘Ÿğ‘œğ‘ ğ¸ğ‘¥ğ‘ > 0 	 Â is	 Â estimated	 Â as	 Â the	 Â baseline	 Â mean	 Â for	 Â the	 Â clinics	 Â that	 Â did	 Â not	 Â 
integrate	 Â from	 Â Table	 Â 3.	 Â 


                                                                                                                                                                                                                                                                          15
                                                                                                                                                              	 Â 


      6.4. 	 Â Control	 Â Group	 Â Validity	 Â 

            6.4.1. Baseline	 Â Balance	 Â 

      Despite	 Â  that	 Â  fact	 Â  that	 Â  larger	 Â  clinics	 Â  chose	 Â  to	 Â  integrate,	 Â  there	 Â  was	 Â  no	 Â  difference	 Â  in	 Â  the	 Â 
types	 Â  patients	 Â  nor	 Â  in	 Â  the	 Â  treatment	 Â  patterns	 Â  between	 Â  clinics	 Â  that	 Â  chose	 Â  to	 Â  integrate	 Â  and	 Â 
those	 Â  that	 Â  did	 Â  not	 Â  (Table	 Â  3,	 Â  Panel	 Â  A).	 Â  This	 Â  rules	 Â  out	 Â  Ashenfelter	 Â  dip	 Â  explanations	 Â  of	 Â  the	 Â 
results.	 Â Specifically,	 Â we	 Â find	 Â no	 Â differences	 Â in	 Â patient	 Â sex	 Â and	 Â or	 Â in	 Â medical	 Â reason	 Â for	 Â the	 Â 
visit.	 Â  Physicians	 Â  in	 Â  both	 Â  types	 Â  of	 Â  clinics	 Â  preform	 Â  diagnostics	 Â  test	 Â  on	 Â  about	 Â  3%	 Â  of	 Â  patients	 Â 
and	 Â  spent	 Â  about	 Â  the	 Â  same	 Â  amount	 Â  on	 Â  those	 Â  tests.	 Â  Physicians	 Â  in	 Â  both	 Â  types	 Â  of	 Â  clinics	 Â  also	 Â 
prescribed	 Â medications	 Â to	 Â almost	 Â all	 Â patients,	 Â prescribed	 Â identical	 Â classes	 Â of	 Â medications,	 Â 
and	 Â prescribed	 Â the	 Â same	 Â amount	 Â in	 Â terms	 Â of	 Â expenditures	 Â on	 Â drugs.	 Â The	 Â one	 Â difference	 Â is	 Â 
that	 Â patients	 Â who	 Â visited	 Â integrated	 Â clinics	 Â were	 Â younger	 Â and	 Â we	 Â explicitly	 Â control	 Â for	 Â this	 Â 
in	 Â all	 Â models.	 Â 

            6.4.2. Pre-Â­â€intervention	 Â Trends	 Â Tests	 Â 

          The	 Â  key	 Â  assumptions	 Â  underlying	 Â  the	 Â  causal	 Â  interpretation	 Â  in	 Â  our	 Â  triple	 Â  differences	 Â 
model	 Â  are	 Â  that	 Â  the	 Â  change	 Â  in	 Â  the	 Â  group	 Â  integrated	 Â  at	 Â  baseline	 Â  is	 Â  an	 Â  unbiased	 Â  estimate	 Â  of	 Â 
what	 Â  would	 Â  have	 Â  been	 Â  the	 Â  change	 Â  in	 Â  the	 Â  group	 Â  not	 Â  integrated	 Â  at	 Â  baseline	 Â  that	 Â  choose	 Â  to	 Â 
integrate	 Â and	 Â an	 Â unbiased	 Â estimate	 Â of	 Â the	 Â group	 Â that	 Â choose	 Â not	 Â to	 Â integrate.	 Â Again,	 Â while	 Â 
we	 Â  cannot	 Â  test	 Â  this	 Â  directly,	 Â  we	 Â  can	 Â  employ	 Â  The	 Â  Heckman-Â­â€Hotz	 Â  tests	 Â  of	 Â  pre-Â­â€intervention	 Â 
trends.	 Â We	 Â have	 Â already	 Â shown	 Â the	 Â there	 Â is	 Â no	 Â difference	 Â in	 Â the	 Â pre-Â­â€intervention	 Â trends	 Â of	 Â 
the	 Â groups	 Â that	 Â were	 Â and	 Â were	 Â not	 Â integrated	 Â at	 Â baseline.	 Â In	 Â this	 Â section,	 Â we	 Â test	 Â equality	 Â of	 Â 
the	 Â pre-Â­â€intervention	 Â trends	 Â of	 Â the	 Â groups	 Â that	 Â were	 Â not	 Â integrated	 Â at	 Â baseline	 Â that	 Â choose	 Â 
to	 Â integrate	 Â and	 Â that	 Â choose	 Â not	 Â to	 Â integrate.	 Â 
          We	 Â implement	 Â the	 Â test	 Â by	 Â dropping	 Â all	 Â post-Â­â€policy	 Â observations	 Â from	 Â our	 Â sample	 Â and	 Â 
estimate	 Â the	 Â following	 Â model	 Â for	 Â the	 Â group	 Â of	 Â clinics	 Â that	 Â were	 Â not	 Â integrated	 Â a	 Â baseline:	 Â 

                               	 Â ğ‘¦!"#$ = ğ›¼! + ğ›¾!" +              ! ğ›¿! ğ‘¥!"#$   +      ! ğœ†! ğ¼!"      ! ğ‘‡ğ‘Ÿğ‘’ğ‘›ğ‘‘!       + ğœ€!"#$ 	 Â            	 Â           (5)	 Â 
                                  	 Â 
where	 Â  Ijk	 Â  is	 Â  a	 Â  dummy	 Â  variable	 Â  indicating	 Â  whether	 Â  physician	 Â  j	 Â in	 Â  municipality	 Â  k	 Â will	 Â  be	 Â  in	 Â  an	 Â 
integrated	 Â group	 Â in	 Â the	 Â post	 Â period,	 Â Trendt	 Â is	 Â a	 Â continuous	 Â time	 Â variable	 Â indicating	 Â quarter,	 Â 
and	 Â all	 Â variables	 Â are	 Â as	 Â defined	 Â for	 Â equation	 Â (3).	 Â The	 Â coefficients	 Â of	 Â interest	 Â are	 Â the	 Â  Î»kâ€™s	 Â on	 Â 
the	 Â interaction	 Â of	 Â the	 Â municipality	 Â dummies,	 Â integration	 Â dummy	 Â and	 Â time	 Â trend.	 Â                                   	 Â 


                                                                                 16
                                                                                                                                                                                                                                                                  	 Â 


	 Â                 We	 Â estimate	 Â equation	 Â (5)	 Â for	 Â each	 Â of	 Â the	 Â dependent	 Â variables.	 Â Almost	 Â all	 Â of	 Â the	 Â  Î»kâ€™	 Â 
(78	 Â out	 Â 80)	 Â are	 Â not	 Â significantly	 Â different	 Â that	 Â zero.	 Â The	 Â hypothesis	 Â that	 Â all	 Â of	 Â the	 Â coefficient	 Â 
interaction	 Â  terms	 Â  are	 Â  jointly	 Â  for	 Â  each	 Â  outcome	 Â  zero	 Â  also	 Â  cannot	 Â  be	 Â  rejected	 Â  at	 Â  conventional	 Â 
significance	 Â levels	 Â for	 Â 4	 Â out	 Â of	 Â the	 Â 5	 Â dependent	 Â variables	 Â (Appendix	 Â Table	 Â A2).	 Â 

       6.5. Placebo	 Â Test	 Â 

                    We	 Â also	 Â estimate	 Â the	 Â triple	 Â differences	 Â model	 Â in	 Â equation	 Â (4)	 Â on	 Â the	 Â sample	 Â of	 Â visits	 Â 
to	 Â  clinics	 Â  by	 Â  patients	 Â  who	 Â  are	 Â  exempt	 Â  from	 Â  the	 Â  separating	 Â  policy	 Â  i.e.	 Â  the	 Â  young	 Â  and	 Â  the	 Â 
elderly.	 Â  Since	 Â  they	 Â  are	 Â  exempt,	 Â  the	 Â  introduction	 Â  of	 Â  the	 Â  separating	 Â  policy	 Â  should	 Â  have	 Â  no	 Â 
effect	 Â on	 Â drug	 Â and	 Â diagnostic	 Â expenditures	 Â for	 Â these	 Â patients.	 Â The	 Â results	 Â are	 Â presented	 Â in	 Â 
Panel	 Â C	 Â of	 Â Table	 Â 5	 Â and	 Â show	 Â little	 Â or	 Â no	 Â effect	 Â of	 Â the	 Â separating	 Â policy.	 Â 

       6.6. An	 Â Alternative	 Â Identification	 Â Strategy	 Â 	 Â 

             As a robustness test we also estimate the triple differences model by using instrumental
variables to control for the possibility that the integration decision was in part in response to
time-varying shocks to specific clinics within municipalities. Our instrument is baseline practice
volume interacted with the timing of the introduction of the separating policy in the clinic as
an instrument for integration.9 The instrument is the empirical analogue of the volume variable
in the theoretical model interacted with whether the policy is active.

                    6.6.1. Instrument	 Â Validity	 Â 

             We have already shown that the instrument is a highly significant predictor of the
probability that the clinic integrates. It is also highly correlated with the outcomes of interest.
Figures 4 and 5 plot the share of visits receiving a prescription and the average drug expenditures
per visit over time separately by four baseline practice volume quartiles. Drug prescriptions rise
the most post-policy for the smallest group and do not rise for the largest groups.
             One potential concern with this instrument, however, is the larger clinics attract different
types of patients and are able to treat those patients with different (better) procedures. However,

         	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
9
 	 Â Specifically, we re-estimate the triple difference model in equation (4) by instrumental variables. We instrument
for treatment times pharmacy with D40 (=1 if the baseline practice volume exceeds 40,000 visits per year) and (1-D40)
Ã— log baseline volume, both interacted with a dummy indicating that the separating policy was active in which the
clinic was located.	 Â 


                                                                                                                                                                                                                                                             17
                                                                                                                                                         	 Â 


baseline clinic volume also does not seem to be correlated with the baseline type of patients,
types of illnesses treated or provider treatment patterns as there is no difference in these variables
between clinics that choose to integrate and those who did not (Table 3 Panel A). Hence it is
unlikely that baseline volume is an independent cause of the outcomes of interest.

           6.6.2. IV	 Â Triple	 Â Difference	 Â Results	 Â 

          The results are presented in panel B of Table 5. The estimate of moral hazard in row (a) is
almost identical to that which we found using the simple triple difference strategy. Specifically,
the separating policy reduced the probability that a physician working in a non-integrated clinic
gave a patient drug prescription by 2.7 percentage points and reduced average drug expenditures
per visit by 4.9 percent. This reduced total drug expenditures by 7.7%. We also find almost
identical effects on diagnostic test expenditures as well and overall total expenditures.
          In contrast to the triple differences results, we do find that integration, row (a) + (b),
increased total expenditures by 2.3% primarily through increased drug expenditures. One reason
may be that clinics without a pharmacy are not able to dispense certain types of drugs and must
refer to an independent pharmacy. By integrating an onsite pharmacist into their practices, they
are now able to dispense these types of drugs and hence can exploit this fact for further gain.

7. Economies	 Â of	 Â Scope	 Â 

          In	 Â this	 Â section	 Â we	 Â examine	 Â potential	 Â gains	 Â from	 Â integration	 Â resulting	 Â from	 Â economies	 Â 
of	 Â  scope	 Â  that	 Â  may	 Â  improve	 Â  quality	 Â  of	 Â  care.	 Â  There	 Â  are	 Â  two	 Â  possible	 Â  routes	 Â  to	 Â  improved	 Â  care.	 Â 
First,	 Â  integration	 Â  could	 Â  improve	 Â  therapy	 Â  adherence,	 Â  i.e.	 Â  patients	 Â  following	 Â  drug	 Â 
prescription	 Â  regimes	 Â  have	 Â  lower	 Â  costs	 Â  of	 Â  filling	 Â  and	 Â  refilling	 Â  prescriptions	 Â  when	 Â 
pharmacies	 Â  are	 Â  located	 Â  in	 Â  the	 Â  physicianâ€™s	 Â  office	 Â  and	 Â  therefore	 Â  have	 Â  better	 Â  adherence	 Â  to	 Â 
their	 Â prescribed	 Â medication	 Â regimes.	 Â 	 Â Second,	 Â integration	 Â may	 Â improve	 Â the	 Â coordination	 Â of	 Â 
care	 Â  through	 Â  better	 Â  communication	 Â  between	 Â  physicians	 Â  and	 Â  pharmacists	 Â  at	 Â  the	 Â 
prescription	 Â phase	 Â resulting	 Â in	 Â improved	 Â treatment	 Â plans.	 Â 	 Â 

     7.1. Therapy	 Â Adherence	 Â 

          We	 Â  examine	 Â  medication	 Â  adherence	 Â  for	 Â  two	 Â  chronic	 Â  diseases	 Â  â€“	 Â  diabetes	 Â  and	 Â 
hypertension.	 Â  Medication	 Â  adherence	 Â  is	 Â  particularly	 Â  important	 Â  for	 Â  both	 Â  type	 Â  of	 Â  patients	 Â 



                                                                               18
                                                                                                                                                                                                                                                                   	 Â 


Persistent	 Â  high	 Â  levels	 Â  of	 Â  blood	 Â  sugar	 Â  can	 Â  have	 Â  immediate	 Â  short-Â­â€term	 Â  effects	 Â  that	 Â  require	 Â 
some	 Â form	 Â of	 Â emergency	 Â treatment	 Â and	 Â blood	 Â pressure	 Â can	 Â spike	 Â even	 Â after	 Â a	 Â two-Â­â€day	 Â drug	 Â 
holiday	 Â  from	 Â  medication	 Â  (Ribeiro	 Â  et	 Â  al.	 Â  2007).	 Â  	 Â  High	 Â  levels	 Â  of	 Â  medication	 Â  adherence	 Â  are	 Â 
associated	 Â with	 Â lower	 Â hospitalization	 Â rates	 Â for	 Â both	 Â types	 Â (Sokol	 Â et	 Â al.,	 Â 2005).	 Â 	 Â 	 Â 
              We	 Â  measure	 Â  therapy	 Â  adherence	 Â  by	 Â  the	 Â  extent	 Â  to	 Â  which	 Â  patients	 Â  with	 Â  chronic	 Â 
diseases	 Â fill	 Â their	 Â drug	 Â prescriptions	 Â on	 Â time.	 Â The	 Â hypothesis	 Â is	 Â that	 Â patients	 Â are	 Â more	 Â likely	 Â 
to	 Â  fill	 Â  drug	 Â  prescriptions	 Â  if	 Â  they	 Â  are	 Â  able	 Â  to	 Â  do	 Â  so	 Â  in	 Â  the	 Â  clinic	 Â  at	 Â  the	 Â  time	 Â  of	 Â  prescription	 Â 
rather	 Â  than	 Â  having	 Â  to	 Â  fill	 Â  them	 Â  later	 Â  at	 Â  a	 Â  pharmacy	 Â  outside	 Â  of	 Â  the	 Â  clinic.	 Â  The	 Â  adherence	 Â 
measure	 Â  is	 Â  the	 Â  share	 Â  of	 Â  days	 Â  per	 Â  quarter	 Â  that	 Â  the	 Â  patient	 Â  has	 Â  medication	 Â  in	 Â  her	 Â  possession,	 Â 
a	 Â common	 Â measure	 Â of	 Â adherence	 Â in	 Â the	 Â medical	 Â literature	 Â (Osterberg	 Â and	 Â Blascke	 Â 2005).	 Â 
              We	 Â  test	 Â  for	 Â  economies	 Â  of	 Â  scope	 Â  in	 Â  therapy	 Â  compliance	 Â  using	 Â  the	 Â  triple	 Â  differences	 Â 
model.	 Â If	 Â integration	 Â improves	 Â adherence	 Â then	 Â the	 Â effect	 Â of	 Â the	 Â policy	 Â on	 Â clinics	 Â that	 Â did	 Â not	 Â 
integrate	 Â should	 Â be	 Â negative	 Â and	 Â there	 Â should	 Â be	 Â no	 Â effect	 Â of	 Â the	 Â policy	 Â on	 Â clinics	 Â that	 Â did	 Â 
integrate.	 Â  We	 Â  find	 Â  no	 Â  effects	 Â  on	 Â  therapy	 Â  adherence	 Â  for	 Â  both	 Â  diabetic	 Â  and	 Â  chronically	 Â  ill	 Â 
hypertensive	 Â patients	 Â (Table	 Â 6).	 Â 	 Â 

      7.2. 	 Â 	 Â Adverse	 Â Events	 Â 

              We	 Â  examine	 Â  adverse	 Â  events	 Â  from	 Â  deficient	 Â  medical	 Â  treatment	 Â  measured	 Â  by	 Â  an	 Â 
avoidable	 Â  ER	 Â  visit	 Â  or	 Â  hospitalization	 Â  shortly	 Â  after	 Â  the	 Â  outpatient	 Â  visits	 Â  to	 Â  clinic.10 	 Â We	 Â 
consider	 Â  adverse	 Â  events	 Â  for	 Â  three	 Â  types	 Â  of	 Â  prevalent	 Â  patient	 Â  diagnoses:	 Â  acute	 Â  respiratory	 Â 
infections	 Â  (ARI),	 Â  diabetes,	 Â  and	 Â  hypertension	 Â  â€“	 Â  the	 Â  most	 Â  prevalent	 Â  chronic	 Â  diseases	 Â  in	 Â  the	 Â 
majority	 Â  of	 Â  industrialized	 Â  economies.	 Â  These	 Â  diseases	 Â  are	 Â  ambulatory	 Â  care	 Â  sensitive	 Â 
conditions	 Â  for	 Â  which	 Â  good	 Â  primary	 Â  care	 Â  and	 Â  drug	 Â  adherence	 Â  can	 Â  drastically	 Â  reduce	 Â  or	 Â  even	 Â 
eliminate	 Â  the	 Â  need	 Â  for	 Â  hospitalizations	 Â  or	 Â  ER	 Â  visits.	 Â  Moreover,	 Â  any	 Â  clinically	 Â  significant	 Â 
interruption	 Â in	 Â treatment	 Â of	 Â diabetes	 Â and	 Â hypertension	 Â is	 Â likely	 Â to	 Â manifest	 Â as	 Â an	 Â adverse	 Â 
event	 Â  in	 Â  a	 Â  relatively	 Â  short	 Â  time-Â­â€horizon	 Â  (Ho	 Â  et	 Â  al.,	 Â  2006,	 Â  Sokol	 Â  et	 Â  al.,	 Â  2005,	 Â  Wu	 Â  et	 Â  al.,	 Â  2009).	 Â 	 Â 
When	 Â  ARI	 Â  is	 Â  not	 Â  treated,	 Â  it	 Â  can	 Â  manifest	 Â  itself	 Â  into	 Â  more	 Â  serious	 Â  problems	 Â  such	 Â  as	 Â 
pneumonia	 Â that	 Â could	 Â require	 Â hospitalization.	 Â 

          	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
10
  	 Â These	 Â avoidable	 Â adverse	 Â events	 Â are	 Â typically	 Â caused	 Â by	 Â deficient	 Â medical	 Â treatment.	 Â See,	 Â for	 Â example,	 Â 
DiMatteo	 Â et	 Â al.	 Â (2002),	 Â Lee	 Â et	 Â al,	 Â (2006),	 Â Mojtabai	 Â and	 Â Olfson	 Â (2003),	 Â Osterberg	 Â and	 Â Blaschke	 Â (2005),	 Â Simpson	 Â 
et	 Â al.	 Â (2006),	 Â and	 Â Tabor	 Â and	 Â Lopez	 Â (2004).	 Â 


                                                                                                                                                                                                                                                              19
                                                                                                                                                         	 Â 


          For	 Â  ARI,	 Â  we	 Â  examine	 Â  ER	 Â  utilization	 Â  and	 Â  inpatient	 Â  admissions	 Â  within	 Â  30	 Â  days	 Â  of	 Â  the	 Â 
office	 Â  visit.	 Â  For	 Â  diabetic	 Â  and	 Â  hypertensive	 Â  patients,	 Â  we	 Â  examine	 Â  ER	 Â  utilization	 Â  and	 Â 
hospitalization	 Â  rates	 Â  within	 Â  360	 Â  days	 Â  of	 Â  the	 Â  visit	 Â  as	 Â  medical	 Â  issues	 Â  associated	 Â  with	 Â 
uncontrolled	 Â diabetes	 Â or	 Â hypertension	 Â can	 Â take	 Â time	 Â to	 Â develop.	 Â 	 Â The	 Â results,	 Â reported	 Â in	 Â 
Table	 Â 7,	 Â show	 Â no	 Â significant	 Â effects	 Â on	 Â either	 Â adverse	 Â event	 Â measure	 Â for	 Â any	 Â of	 Â the	 Â diseases.	 Â 	 Â 

8. Conclusions	 Â 

         A	 Â  concern	 Â  of	 Â  anyone	 Â  who	 Â  consults	 Â  a	 Â  doctor,	 Â  plumber,	 Â  or	 Â  auto	 Â  mechanic	 Â  is	 Â  the	 Â 
incentive	 Â to	 Â give	 Â advice	 Â that	 Â is	 Â not	 Â in	 Â the	 Â buyer's	 Â best	 Â interests.	 Â Nowhere	 Â is	 Â this	 Â truer	 Â than	 Â 
when	 Â physicians	 Â have	 Â an	 Â ownership	 Â interest	 Â in	 Â complementary	 Â medical	 Â services,	 Â and	 Â is	 Â the	 Â 
reason	 Â  that	 Â  led	 Â  to	 Â  the	 Â  Stark	 Â  Law	 Â  that	 Â  prohibits	 Â  referrals	 Â  of	 Â  Medicare	 Â  and	 Â  Medicaid	 Â  patients	 Â 
to	 Â complementary	 Â care	 Â facilities	 Â in	 Â which	 Â the	 Â physicians	 Â have	 Â a	 Â financial	 Â interest.	 Â 	 Â 
         In	 Â this	 Â paper,	 Â we	 Â investigated	 Â a	 Â Stark-Â­â€like	 Â policy	 Â in	 Â Taiwan	 Â that	 Â prohibited	 Â physicians	 Â 
from	 Â  owning	 Â  pharmacies	 Â  and	 Â  dispensing	 Â  drugs	 Â  unless	 Â  they	 Â  had	 Â  an	 Â  onsite	 Â  pharmacy.	 Â  We	 Â 
find	 Â  that	 Â  the	 Â  policy	 Â  reduced	 Â  drug	 Â  expenditures	 Â  among	 Â  physicians	 Â  that	 Â  did	 Â  not	 Â  have	 Â  an	 Â 
onsite	 Â  pharmacy.	 Â  However,	 Â  the	 Â  overall	 Â  effectiveness	 Â  of	 Â  the	 Â  policy	 Â  in	 Â  reducing	 Â  costs	 Â  was	 Â 
mitigated	 Â by	 Â increased	 Â overprovision	 Â of	 Â diagnostic	 Â services	 Â not	 Â covered	 Â by	 Â the	 Â policy,	 Â and	 Â 
many	 Â of	 Â clinics	 Â that	 Â did	 Â not	 Â have	 Â an	 Â onsite	 Â pharmacy	 Â prior	 Â to	 Â the	 Â policy	 Â integrated	 Â onsite	 Â 
pharmacies	 Â into	 Â their	 Â practices	 Â to	 Â become	 Â exempt	 Â from	 Â policy.	 Â In	 Â the	 Â end,	 Â the	 Â policy	 Â only	 Â 
applied	 Â to	 Â less	 Â than	 Â 40%	 Â of	 Â clinics.	 Â As	 Â a	 Â result,	 Â the	 Â separating	 Â policy	 Â only	 Â reduced	 Â aggregate	 Â 
outpatient	 Â expenditures	 Â by	 Â less	 Â than	 Â 1	 Â percent.	 Â 	 Â 
         Despite	 Â  this	 Â  policymakers	 Â  are	 Â  correct	 Â  to	 Â  be	 Â  concerned	 Â  about	 Â  physicians	 Â  referring	 Â 
patients	 Â  to	 Â  an	 Â  entity	 Â  in	 Â  which	 Â  they	 Â  have	 Â  a	 Â  financial	 Â  interest	 Â  because	 Â  of	 Â  the	 Â  potential	 Â  for	 Â 
overtreatment.	 Â Our	 Â results	 Â do	 Â show	 Â that	 Â moral	 Â hazard	 Â costs	 Â of	 Â self-Â­â€referral	 Â incentives	 Â are	 Â 
significant.	 Â Physicians	 Â that	 Â own	 Â pharmacies	 Â prescribe	 Â 7.6%	 Â more	 Â drugs	 Â to	 Â outpatients	 Â than	 Â 
physicians	 Â that	 Â do	 Â own	 Â pharmacies.	 Â 	 Â 	 Â 
         The	 Â bright-Â­â€line	 Â of	 Â the	 Â safe	 Â harbor	 Â exception	 Â appears	 Â to	 Â be	 Â misguided	 Â as	 Â appear	 Â to	 Â be	 Â 
no	 Â evidence	 Â economies	 Â of	 Â scope	 Â efficiency	 Â justifications	 Â from	 Â the	 Â integration	 Â of	 Â pharmacies	 Â 
into	 Â physician	 Â practices.	 Â Specifically,	 Â we	 Â do	 Â not	 Â find	 Â that	 Â the	 Â convenience	 Â of	 Â collecting	 Â oneâ€™s	 Â 
prescriptions	 Â  before	 Â  leaving	 Â  the	 Â  physician	 Â  office	 Â  improves	 Â  adherence	 Â  to	 Â  drug	 Â  therapy	 Â 
among	 Â diabetic	 Â and	 Â chronically	 Â ill	 Â hypertensive	 Â patients.	 Â 	 Â Nor	 Â do	 Â we	 Â find	 Â that	 Â integration	 Â 


                                                                               20
                                                                                                                                                	 Â 


improves	 Â  coordination	 Â  of	 Â  care	 Â  enough	 Â  to	 Â  reduce	 Â  adverse	 Â  events	 Â  for	 Â  patients	 Â  with	 Â  diabetes,	 Â 
hypertension	 Â or	 Â ARI.	 Â 
         Providing	 Â  safe	 Â  harbor	 Â  exceptions	 Â  ultimately	 Â  voids	 Â  the	 Â  very	 Â  purpose	 Â  of	 Â  the	 Â  original	 Â 
prohibition	 Â  as	 Â  physicians	 Â  exploit	 Â  these	 Â  loopholes	 Â  to	 Â  continue	 Â  to	 Â  engage	 Â  in	 Â  profitable	 Â  self-Â­â€
referrals.	 Â  	 Â  The	 Â  â€œsafe	 Â  harborâ€	 Â  exemption	 Â  only	 Â  encourages	 Â  physicians	 Â  to	 Â  integrate	 Â 
complementary	 Â  into	 Â  their	 Â  practices	 Â  thereby	 Â  increasing	 Â  costs	 Â  from	 Â  moral	 Â  hazard	 Â  without	 Â 
any	 Â off	 Â setting	 Â gains	 Â in	 Â efficiency	 Â from	 Â economies	 Â of	 Â scope.	 Â 	 Â 	 Â 
	 Â                                           	 Â 




                                                                              21
                                                                                                                                                                                    	 Â 


                                                                              References	 Â 
Afendulis,	 Â  CC	 Â  and	 Â  DP	 Â  Kessler.	 Â  2007.	 Â  "Tradeoffs	 Â  from	 Â  Integrating	 Â  Diagnosis	 Â  and	 Â  Treatment	 Â  in	 Â 
    Markets	 Â for	 Â Health	 Â Care."	 Â The	 Â American	 Â Economic	 Â Review,	 Â 97(3),	 Â 1013-Â­â€20.	 Â 
Aronovitz,	 Â L.	 Â G.	 Â 1994.	 Â "Referrals	 Â to	 Â Physician-Â­â€Owned	 Â Imaging	 Â Facilities	 Â Warrant	 Â HCFA	 Â Scrutiny:	 Â 
   GAO	 Â Report	 Â to	 Â the	 Â U.S.	 Â House	 Â of	 Â Representatives."	 Â Washington,	 Â DC:	 Â GAO,	 Â 5,	 Â 95â€“2.	 Â 
Cheng,	 Â T.M.	 Â 2003.	 Â "Taiwan's	 Â New	 Â National	 Â Health	 Â Insurance	 Â Program."	 Â Health	 Â Aff,	 Â 22(3),	 Â 61-Â­â€76.	 Â 
Chevalier,	 Â  J	 Â  and	 Â  G	 Â  Ellison.	 Â  1997.	 Â  "Risk	 Â  Taking	 Â  by	 Â  Mutual	 Â  Funds	 Â  as	 Â  a	 Â  Response	 Â  to	 Â  Incentives."	 Â 
   Journal	 Â of	 Â Political	 Â Economy,	 Â 105(6),	 Â 1167-Â­â€200.	 Â 
Childs,	 Â A.	 Â W.	 Â and	 Â E.	 Â D.	 Â Hunter.	 Â 1972.	 Â "Non-Â­â€Medical	 Â Factors	 Â Influencing	 Â Use	 Â of	 Â Diagnostic	 Â X-Â­â€Ray	 Â 
    by	 Â Physicians."	 Â Med	 Â Care,	 Â 10(4),	 Â 323-Â­â€35.	 Â 
Chou,	 Â Y.	 Â J.;	 Â W.	 Â C.	 Â Yip;	 Â C.	 Â H.	 Â Lee;	 Â N.	 Â Huang;	 Â Y.	 Â P.	 Â Sun	 Â and	 Â H.	 Â J.	 Â Chang.	 Â 2003.	 Â "Impact	 Â of	 Â Separating	 Â 
   Drug	 Â  Prescribing	 Â  and	 Â  Dispensing	 Â  on	 Â  Provider	 Â  Behaviour:	 Â  Taiwan's	 Â  Experience."	 Â  Health	 Â 
   Policy	 Â and	 Â Planning,	 Â 18(3),	 Â 316-Â­â€29.	 Â 
DiMatteo,	 Â MR;	 Â PJ	 Â Giordani;	 Â HS	 Â Lepper	 Â and	 Â TW	 Â Croghan.	 Â 2002.	 Â "Patient	 Â Adherence	 Â and	 Â Medical	 Â 
   Treatment	 Â Outcomes	 Â a	 Â Meta-Â­â€Analysis."	 Â Medical	 Â Care,	 Â 40(9),	 Â 794-Â­â€811.	 Â 
Dranove,	 Â D.	 Â 1988.	 Â "Demand	 Â Inducement"	 Â Economic	 Â Inquiry,	 Â 26(2),	 Â 281-Â­â€98.	 Â 
Eggleston,	 Â Karen	 Â ed.	 Â 2009.	 Â Pharmaceutical	 Â Policy	 Â in	 Â the	 Â Asia-Â­â€Pacific.	 Â Brookings	 Â Institution	 Â Press.	 Â 
Fuchs,	 Â V.	 Â R.	 Â 1978.	 Â "The	 Â Supply	 Â of	 Â Surgeons	 Â and	 Â the	 Â Demand	 Â for	 Â Operations."	 Â JHR,	 Â 13(0),	 Â 35-Â­â€56.	 Â 
Gazelle,	 Â GS;	 Â EF	 Â Halpern;	 Â HS	 Â Ryan	 Â and	 Â AC	 Â Tramontano.	 Â 2007.	 Â "Utilization	 Â of	 Â Diagnostic	 Â Medical	 Â 
    Imaging:	 Â Radiologist	 Â Referral	 Â Versus	 Â Same-Â­â€Specialty	 Â Referral."	 Â Radiology,	 Â 245(2),	 Â 517.	 Â 
Gruber,	 Â  Jonathan	 Â  and	 Â  Maria	 Â  Owings.	 Â  1996.	 Â  "Physician	 Â  Financial	 Â  Incentives	 Â  and	 Â  Cesarean	 Â 
   Section	 Â Delivery."	 Â Rand	 Â Journal	 Â of	 Â Economics,	 Â 27(1),	 Â 99-Â­â€123.	 Â 
Hillman,	 Â  B.	 Â  J.;	 Â  C.	 Â  A.	 Â  Joseph;	 Â  M.	 Â  R.	 Â  Mabry;	 Â  J.	 Â  H.	 Â  Sunshine;	 Â  S.	 Â  D.	 Â  Kennedy	 Â  and	 Â  M.	 Â  Noether.	 Â  1990.	 Â 
    "Frequency	 Â  and	 Â  Costs	 Â  of	 Â  Diagnostic	 Â  Imaging	 Â  in	 Â  Office	 Â  Practice-Â­â€-Â­â€a	 Â  Comparison	 Â  of	 Â  Self-Â­â€
    Referring	 Â  and	 Â  Radiologist-Â­â€Referring	 Â  Physicians."	 Â New	 Â England	 Â Journal	 Â of	 Â Medicine,	 Â  323(23),	 Â 
    1604.	 Â 
Hillman,	 Â B.J.;	 Â G.T.	 Â Olson;	 Â R.W.	 Â Colbert	 Â and	 Â L.B.	 Â Bernhardt.	 Â 1995.	 Â "Responses	 Â to	 Â Denying	 Â Charges	 Â 
    for	 Â Diagnostic	 Â Imaging	 Â by	 Â Nonradiologist	 Â Physicians."	 Â JAMA,	 Â 274(11),	 Â 885-Â­â€87.	 Â 
Hillman,	 Â B.	 Â J.;	 Â G.	 Â T.	 Â Olson;	 Â P.	 Â E.	 Â Griffith;	 Â J.	 Â H.	 Â Sunshine;	 Â C.	 Â A.	 Â Joseph;	 Â S.	 Â D.	 Â Kennedy;	 Â W.	 Â R.	 Â Nelson	 Â 
    and	 Â  L.	 Â  B.	 Â  Bernhardt.	 Â  1992.	 Â  "Physicians'	 Â  Utilization	 Â  and	 Â  Charges	 Â  for	 Â  Outpatient	 Â  Diagnostic	 Â 
    Imaging	 Â in	 Â a	 Â Medicare	 Â Population."	 Â JAMA,	 Â 268(15),	 Â 2050-Â­â€54.	 Â 
Ho,	 Â  P.	 Â  M.;	 Â  J.	 Â  S.	 Â  Rumsfeld;	 Â  F.	 Â  A.	 Â  Masoudi;	 Â  D.	 Â  L.	 Â  McClure;	 Â  M.	 Â  E.	 Â  Plomondon;	 Â  J.	 Â  F.	 Â  Steiner	 Â  and	 Â  D.	 Â  J.	 Â 
        Magid.	 Â 2006.	 Â "Effect	 Â of	 Â Medication	 Â Nonadherence	 Â on	 Â Hospitalization	 Â and	 Â Mortality	 Â among	 Â 
        Patients	 Â with	 Â Diabetes	 Â Mellitus."	 Â Arch	 Â Intern	 Â Med,	 Â 166(17),	 Â 1836-Â­â€41.	 Â 
Hubbard,	 Â  TN.	 Â  1998.	 Â  "An	 Â  Empirical	 Â  Examination	 Â  of	 Â  Moral	 Â  Hazard	 Â  in	 Â  the	 Â  Vehicle	 Â  Inspection	 Â 
   Market."	 Â Rand	 Â Journal	 Â of	 Â Economics,	 Â 29(2),	 Â 406-Â­â€26.	 Â 
Hubbard,	 Â TN.	 Â 2002.	 Â "How	 Â Do	 Â Consumers	 Â Motivate	 Â Experts?	 Â Reputational	 Â Incentives	 Â in	 Â an	 Â Auto	 Â 
   Repair	 Â Market."	 Â Journal	 Â of	 Â Law	 Â and	 Â Economics,	 Â 437-Â­â€68.	 Â 


                                                                                                 22
                                                                                                                                                                             	 Â 


Iizuka,	 Â  T.	 Â  2007.	 Â  "Experts'	 Â  Agency	 Â  Problems:	 Â  Evidence	 Â  from	 Â  the	 Â  Prescription	 Â  Drug	 Â  Market	 Â  in	 Â 
    Japan."	 Â The	 Â RAND	 Â Journal	 Â of	 Â Economics,	 Â 38(3),	 Â 844-Â­â€62.	 Â 
Lee,	 Â Jeannie	 Â K.;	 Â Karen	 Â A.	 Â Grace	 Â and	 Â Allen	 Â J.	 Â Taylor.	 Â 2006.	 Â "Effect	 Â of	 Â a	 Â Pharmacy	 Â Care	 Â Program	 Â on	 Â 
     Medication	 Â  Adherence	 Â  and	 Â  Persistence,	 Â  Blood	 Â  Pressure,	 Â  and	 Â  Low-Â­â€Density	 Â  Lipoprotein	 Â 
     Cholesterol."	 Â JAMA:	 Â The	 Â Journal	 Â of	 Â the	 Â American	 Â Medical	 Â Association,	 Â 296(21),	 Â 2563-Â­â€71.	 Â 
Levitt,	 Â  SD	 Â  and	 Â  C	 Â  Syverson.	 Â  2008.	 Â  "Market	 Â  Distortions	 Â  When	 Â  Agents	 Â  Are	 Â  Better	 Â  Informed:	 Â  The	 Â 
    Value	 Â of	 Â Information	 Â in	 Â Real	 Â Estate	 Â Transactions."	 Â Review	 Â of	 Â Economics	 Â and	 Â Statistics,	 Â 90(4),	 Â 
    599-Â­â€611.	 Â 
Lu,	 Â Jui-Â­â€Fen	 Â Rachel	 Â and	 Â William	 Â C.	 Â Hsiao.	 Â 2003.	 Â "Does	 Â Universal	 Â Health	 Â Insurance	 Â Make	 Â Health	 Â 
        Care	 Â Unaffordable?	 Â Lessons	 Â from	 Â Taiwan."	 Â Health	 Â Aff,	 Â 22(3),	 Â 77-Â­â€88.	 Â 
McGuire,	 Â T.	 Â G.	 Â 2000.	 Â Physician	 Â Agency.	 Â 
McGuire,	 Â T.	 Â G.	 Â and	 Â M.	 Â V.	 Â Pauly.	 Â 1991.	 Â "Physician	 Â Response	 Â to	 Â Fee	 Â Changes	 Â with	 Â Multiple	 Â Payers."	 Â 
   Journal	 Â of	 Â Health	 Â Economics,	 Â 10(4),	 Â 385-Â­â€410.	 Â 
Mitchell,	 Â J.	 Â M.	 Â 2005.	 Â "Effects	 Â of	 Â Physician-Â­â€Owned	 Â Hospitals."	 Â Health	 Â Affairs,	 Â 24,	 Â 481-Â­â€90.	 Â 
Mitchell,	 Â J.	 Â M.	 Â and	 Â T.	 Â R.	 Â Sass.	 Â 1995.	 Â "Physician	 Â Ownership	 Â of	 Â Ancillary	 Â Services:	 Â Indirect	 Â Demand	 Â 
    Inducement	 Â or	 Â Quality	 Â Assurance?"	 Â Journal	 Â of	 Â Health	 Â Economics,	 Â 14(3),	 Â 263-Â­â€89.	 Â 
Mitchell,	 Â  JM.	 Â  2008.	 Â  "Utilization	 Â  Trends	 Â  for	 Â  Advanced	 Â  Imaging	 Â  Procedures:	 Â  Evidence	 Â  from	 Â 
    Individuals	 Â with	 Â Private	 Â Insurance	 Â Coverage	 Â in	 Â California."	 Â Medical	 Â Care,	 Â 46(5),	 Â 460.	 Â 
Mojtabai,	 Â  Ramin	 Â  and	 Â  Mark	 Â  Olfson.	 Â  2003.	 Â  "Medication	 Â  Costs,	 Â  Adherence,	 Â  and	 Â  Health	 Â  Outcomes	 Â 
    among	 Â Medicare	 Â Beneficiaries."	 Â Health	 Â Affairs,	 Â 22(4),	 Â 220-Â­â€29.	 Â 
Osterberg,	 Â L	 Â and	 Â Terrence	 Â B.	 Â 2005.	 Â "Adherence	 Â to	 Â Medication."	 Â NEJM,	 Â 353(5),	 Â 487-Â­â€97.	 Â 
Simpson,	 Â  S.	 Â  H,;	 Â  D.	 Â  T.	 Â  Eurich;	 Â  S.	 Â  R.	 Â  Majumdar;	 Â  R.	 Â  S.	 Â  Padwal;	 Â  R.	 Â  T.	 Â  Tsuyuki;	 Â  J.	 Â  Varney	 Â  and	 Â  J.	 Â  A.	 Â 
   Johnson.	 Â  2006.	 Â  "A	 Â  Meta-Â­â€Analysis	 Â  of	 Â  the	 Â  Association	 Â  between	 Â  Adherence	 Â  to	 Â  Drug	 Â  Therapy	 Â 
   and	 Â Mortality."	 Â BMJ,	 Â 333(7557),	 Â 15.	 Â 
Sokol,	 Â  M.C.;	 Â  K.A.	 Â  McGuigan;	 Â  R.R.	 Â  Verbrugge	 Â  and	 Â  R.S.	 Â  Epstein.	 Â  2005.	 Â  "Impact	 Â  of	 Â  Medication	 Â 
   Adherence	 Â on	 Â Hospitalization	 Â Risk	 Â and	 Â Healthcare	 Â Cost."	 Â Medical	 Â Care,	 Â 43(6),	 Â 521.	 Â 
Strasser,	 Â R.	 Â P.;	 Â M.	 Â J.	 Â Bass	 Â and	 Â M.	 Â Brennan.	 Â 1987.	 Â "The	 Â Effect	 Â of	 Â an	 Â on-Â­â€Site	 Â Radiology	 Â Facility	 Â on	 Â 
    Radiologic	 Â Utilization	 Â in	 Â Family	 Â Practice."	 Â J	 Â Fam	 Â Pract,	 Â 24(6),	 Â 619-Â­â€23.	 Â 
Tabor,	 Â P.A.	 Â and	 Â D.A.	 Â Lopez.	 Â 2004.	 Â "Comply	 Â with	 Â Us:	 Â Improving	 Â Medication	 Â Adherence."	 Â Journal	 Â 
   of	 Â Pharmacy	 Â Practice,	 Â 17(3),	 Â 167-Â­â€81.	 Â 
Taylor,	 Â C.	 Â R.	 Â 1995.	 Â "The	 Â Economics	 Â of	 Â Breakdowns,	 Â Checkups,	 Â and	 Â Cures."	 Â JPE,	 Â 103(1),	 Â 53.	 Â 
Tynan,	 Â  A;	 Â  RA	 Â  Berenson	 Â  and	 Â  JB	 Â  Christianson.	 Â  2008.	 Â  "Health	 Â  Plans	 Â  Target	 Â  Advanced	 Â  Imaging	 Â 
   Services:	 Â  Cost,	 Â  Quality	 Â  and	 Â  Safety	 Â  Concerns	 Â  Prompt	 Â  Renewed	 Â  Oversight."	 Â  Issue	 Â brief	 Â (Center	 Â 
   for	 Â Studying	 Â Health	 Â System	 Â Change),	 Â (118),	 Â 1.	 Â 
United	 Â  States	 Â  Government	 Â  Accountability	 Â  Office.	 Â  2008.	 Â  "Rapid	 Â  Spending	 Â  Growth	 Â  and	 Â  Shift	 Â  to	 Â 
    Physician	 Â Offices	 Â Indicate	 Â Need	 Â for	 Â Additional	 Â Management	 Â Practices,"	 Â U.	 Â S.	 Â G.	 Â A.	 Â Office,	 Â 	 Â 
Wagstaff,	 Â  Adam.	 Â  2007.	 Â  "Health	 Â  Systems	 Â  in	 Â  East	 Â  Asia:	 Â  What	 Â  Can	 Â  Developing	 Â  Countries	 Â  Learn	 Â 
   from	 Â Japan	 Â and	 Â the	 Â Asian	 Â Tigers?"	 Â Health	 Â Economics,	 Â 16(5),	 Â 441-Â­â€56.	 Â 


                                                                                             23
                                                                                                                                                       	 Â 


Wolinsky,	 Â  A.	 Â  1993.	 Â  "Competition	 Â  in	 Â  a	 Â  Market	 Â  for	 Â  Informed	 Â  Experts'	 Â  Services."	 Â  Rand,	 Â  24(3),	 Â  380-Â­â€
   98.	 Â 
Wu,	 Â P.H.;	 Â C.Y.	 Â Yang;	 Â Z.L.	 Â Yao;	 Â W.Z.	 Â Lin;	 Â L.W.	 Â Wu	 Â and	 Â C.C.	 Â Chang.	 Â 2009.	 Â "	 Â Blood	 Â Pressure	 Â Control	 Â 
     and	 Â  Hospitalization	 Â  to	 Â  Medication	 Â  Adherence	 Â  among	 Â  Patients	 Â  with	 Â  Hypertension	 Â  in	 Â 
     Taiwan."	 Â American	 Â journal	 Â of	 Â hypertension,	 Â 23(2),	 Â 155-Â­â€60.	 Â 
              	 Â 
	 Â 
       	 Â                                        	 Â 




                                                                                24
                                                                                                                                                                                                                                                                                                                                                                 	 Â 


	 Â 
                                     Table	 Â 1:	 Â Baseline	 Â (1997)	 Â Means	 Â for	 Â Clinics	 Â by	 Â Integration	 Â Status	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
                                                     Prior	 Â to	 Â Separating	 Â Policy	 Â Implementation	 Â 

       	 Â 	 Â                                                                                                                              Not	 Â integrated	 Â                                              Integrated	 Â in	 Â 
                                                                                                                                                                                                                                                                                    Difference	 Â 
       	 Â                                                                                                                                     in	 Â 1997	 Â                                                      1997	 Â 

       Panel	 Â A:	 Â Office	 Â Visit	 Â Characteristics	 Â 
                                                                                                                                                                            	 Â                                                            	 Â                                                               	 Â 
                                                                      Patient	 Â is	 Â female	 Â 	 Â                                                                0.57	 Â 	 Â                                                    0.55	 Â 	 Â                                                       0.02	 Â 

                                                                                          Patient	 Â age	 Â                                                       33.09	 Â 	 Â                                                   28.61	 Â 	 Â                                                 4.48***	 Â 

                                                              Respiratory	 Â illness	 Â 	 Â                                                                         0.42	 Â 	 Â                                                    0.45	 Â 	 Â                                                     -Â­â€0.03	 Â 

                                                  Any	 Â drug	 Â prescription	 Â 	 Â                                                                                0.98	 Â 	 Â                                                    0.98	 Â 	 Â                                                            0	 Â 

                            Antacids/absorbents	 Â prescribed	 Â 	 Â                                                                                                0.19	 Â 	 Â                                                    0.24	 Â 	 Â                                                     -Â­â€0.05	 Â 

                               Anti-Â­â€inflammatory	 Â prescribed	 Â 	 Â                                                                                             0.15	 Â 	 Â                                                    0.19	 Â 	 Â                                                     -Â­â€0.04	 Â 

                         Analgesics/Antipyretics	 Â prescribed	 Â 	 Â                                                                                               0.32	 Â 	 Â                                                    0.36	 Â 	 Â                                                     -Â­â€0.04	 Â 

                                             Expectorant	 Â prescribed	 Â 	 Â                                                                                       0.04	 Â 	 Â                                                    0.05	 Â 	 Â                                                     -Â­â€0.01	 Â 

                                                              Drug	 Â expenditures	 Â                                                                             88.07	 Â 	 Â                                                   92.55	 Â 	 Â                                                      -Â­â€4.48	 Â 

                                             Diagnostic	 Â test	 Â ordered	 Â 	 Â                                                                                   0.03	 Â 	 Â                                                    0.03	 Â 	 Â                                                            0	 Â 

                                 Diagnostic	 Â test	 Â expenditures	 Â 	 Â                                                                                     238.76	 Â 	 Â                                                   259.24	 Â 	 Â                                                     -Â­â€20.48	 Â 

                             Physician	 Â services	 Â expenditures	 Â 	 Â                                                                                      244.28	 Â 	 Â                                                   239.00	 Â 	 Â                                                         5.28	 Â 

                                                              Total	 Â expenditures	 Â                                                                         377.48	 Â 	 Â                                                   352.54	 Â 	 Â                                                      24.94	 Â 

                                           Number	 Â of	 Â observations	 Â                                                                                     65,964	 Â 	 Â                                                   96,669	 Â 	 Â 
                                                                                                                                                                                                                                                                                                             	 Â 
       Panel	 Â B:	 Â Clinic	 Â characteristics	 Â 
                                                                                                                                                                            	 Â                                                            	 Â                                               	 Â 
                                                                                                                                                                                                                                                                                           -Â­â€
                  	 Â       Monthly	 Â practice	 Â volume	 Â (visits)	 Â                                                                                    1,591.34	 Â 	 Â                                                 2,650.85	 Â 	 Â 
                                                                                                                                                                                                                                                                                      1,059.51***	 Â 
                            Monthly	 Â revenues	 Â (in	 Â 1000	 Â NT$)	 Â                                                                                      686.80	 Â 	 Â                                                1,085.11	 Â                                                 -Â­â€398.31***	 Â 

                                           Number	 Â of	 Â observations	 Â                                                                                        3,420	 Â 	 Â                                                   1,826	 Â 	 Â                                                              	 Â 	 Â 

       Notes:	 Â The	 Â sample	 Â is	 Â visits	 Â to	 Â clinics	 Â by	 Â patients	 Â between	 Â older	 Â than	 Â 3	 Â and	 Â younger	 Â than	 Â 60	 Â for	 Â 
       diagnoses	 Â covered	 Â under	 Â the	 Â separating	 Â policy.	 Â Integrated	 Â is	 Â defined	 Â as	 Â having	 Â onsite	 Â pharmacy	 Â 
       prior	 Â to	 Â the	 Â implementation	 Â of	 Â the	 Â separating	 Â policy	 Â in	 Â the	 Â township	 Â in	 Â which	 Â the	 Â clinic	 Â is	 Â 
       located.	 Â 	 Â Expenditures	 Â are	 Â reported	 Â in	 Â 1997	 Â New	 Â Taiwanese	 Â Dollars.	 Â Expenditures	 Â for	 Â drugs	 Â 
       and	 Â diagnostic	 Â tests	 Â are	 Â conditional	 Â on	 Â positive	 Â expenditure.	 Â Statistical	 Â significance	 Â levels	 Â for	 Â 
       tests	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â the	 Â difference	 Â in	 Â means	 Â is	 Â zero	 Â are	 Â marked	 Â as	 Â ***	 Â indicating	 Â p	 Â <	 Â 
       0.01	 Â and	 Â **	 Â indicating	 Â p	 Â <	 Â 0.05.	 Â The	 Â hypothesis	 Â tests	 Â are	 Â conducted	 Â clustering	 Â standard	 Â errors	 Â at	 Â 
       the	 Â township	 Â level.	 Â 	 Â 
         	 Â 
                                                                                      	 Â 




                                                                                                                                                                    25
                                                                                                                                                                                                                             	 Â 


                                                                             Table	 Â 2:	 Â Reduced	 Â Form	 Â Impact	 Â of	 Â Separating	 Â Policy	 Â 
	 Â 
                                                                                                                                                                           Log	 Â physician	 Â 
                                                                                 Log	 Â drug	 Â              Any	 Â Diagnostic	 Â          Log	 Â diagnostic	 Â                                           Log	 Â total	 Â 
                                             Any	 Â Prescription	 Â                                                                                                          services	 Â 
                       	 Â                                                     expenditures	 Â                       Test	 Â                expenditures	 Â                                             expenditures	 Â 
                                                                                                                                                                           expenditures	 Â 
       Panel	 Â A:	 Â Sample	 Â of	 Â visits	 Â to	 Â all	 Â clinics	 Â by	 Â non-Â­â€infant	 Â and	 Â non-Â­â€elderly	 Â patients	 Â 	 Â 
                     Treatment	 Â                -Â­â€0.014***	 Â                   -Â­â€0.038**	 Â                    0.003**	 Â                     -Â­â€0.024	 Â                    0.000	 Â                 -Â­â€0.013***	 Â 
                              	 Â                   (0.002)	 Â                       (0.018)	 Â                    (0.001)	 Â                    (0.022)	 Â                     (0.002)	 Â                   (0.005)	 Â 
                              Mean	 Â                0.97	 Â                         96.15	 Â                         0.04	 Â                    255.14	 Â                       254.31	 Â                  377.31	 Â 
                 Observations	 Â                  871,319	 Â                       641,627	 Â                      871,319	 Â                    35,030	 Â                      871,319	 Â                 673,899	 Â 
                  #	 Â Physicians	 Â                8,821	 Â                         8,144	 Â                        8,821	 Â                     3,494	 Â                        8,821	 Â                   8,399	 Â 
       Panel	 Â B:	 Â Sample	 Â of	 Â visits	 Â to	 Â clinics	 Â not	 Â integrated	 Â at	 Â baseline	 Â by	 Â non-Â­â€infant	 Â and	 Â non-Â­â€elderly	 Â patients	 Â 	 Â 
                     Treatment	 Â                -Â­â€0.012***	 Â                     -Â­â€0.024	 Â                      0.003	 Â                     -Â­â€0.014	 Â                    -Â­â€0.004	 Â              -Â­â€0.016***	 Â 
                                                    (0.002)	 Â                     (0.018)	 Â                       (0.002)	 Â                   (0.024)	 Â                     (0.002)	 Â                   (0.005)	 Â 
                              Mean	 Â 	 Â            0.96	 Â                         95.51	 Â                         0.04	 Â                    247.19	 Â                       266.29	 Â                  388.03	 Â 
                 Observations	 Â                  428,205	 Â                       308,602	 Â                      428,205	 Â                    18,457	 Â                      428,205	 Â                 329,895	 Â 
                  #	 Â Physicians	 Â                6,097	 Â                         5,462	 Â                        6,097	 Â                     2,130	 Â                        6,097	 Â                   5,710	 Â 
       Panel	 Â C:	 Â Falsification	 Â test	 Â -Â­â€	 Â Sample	 Â of	 Â visits	 Â to	 Â all	 Â clinics	 Â by	 Â infants	 Â and	 Â elderly	 Â patients	 Â exempt	 Â from	 Â separating	 Â policy	 Â 	 Â 
                     Treatment	 Â                   -Â­â€0.004	 Â                     -Â­â€0.002	 Â                      -Â­â€0.001	 Â                  0.031	 Â                       -Â­â€0.001	 Â                -Â­â€0.004	 Â 
                              	 Â                  (0.003)	 Â                      (0.026)	 Â                       (0.002)	 Â                   (0.086)	 Â                     (0.004)	 Â                 (0.008)	 Â 
                              Mean	 Â                0.97	 Â                         91.63	 Â                         0.03	 Â                    225.78	 Â                       275.32	 Â                  394.92	 Â 
                 Observations	 Â                  135,605	 Â                        97,376	 Â                      135,605	 Â                     4,226	 Â                      135,605	 Â                 101,203	 Â 
                  #	 Â Physicians	 Â                7,382	 Â                         6,682	 Â                        7,382	 Â                     1,569	 Â                        7,382	 Â                   6,839	 Â 

       Notes:	 Â  Each	 Â column	 Â of	 Â each	 Â panel	 Â reports	 Â the	 Â coefficient	 Â and	 Â standard	 Â error	 Â of	 Â the	 Â difference	 Â in	 Â difference	 Â estimate	 Â of	 Â the	 Â effect	 Â of	 Â the	 Â 
       separating	 Â policy	 Â on	 Â the	 Â dependent	 Â variable	 Â controlling	 Â for	 Â clinic	 Â fixed	 Â effects,	 Â quarter	 Â by	 Â municipality	 Â fixed	 Â effects,	 Â patient	 Â age,	 Â patient	 Â 
       sex,	 Â and	 Â patient	 Â diagnosis.	 Â Each	 Â column	 Â represents	 Â a	 Â different	 Â dependent	 Â variable	 Â and	 Â each	 Â panel	 Â a	 Â different	 Â sample.	 Â The	 Â standard	 Â errors	 Â 
       are	 Â clustered	 Â at	 Â the	 Â township	 Â level.	 Â Statistical	 Â significance	 Â levels	 Â for	 Â tests	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â the	 Â coefficient	 Â estimate	 Â is	 Â zero	 Â are	 Â 
       marked	 Â as	 Â ***	 Â indicating	 Â p	 Â <	 Â 0.01	 Â and	 Â **	 Â indicating	 Â p	 Â <	 Â 0.05.	 Â 
                                                                                                             	 Â 




                                                                                                                           26
                                                                                                                                                                                                                                                	 Â 


	 Â                             Table	 Â 3:	 Â Baseline	 Â (1997)	 Â Means	 Â for	 Â Clinics	 Â Not	 Â Integrated	 Â at	 Â Baseline	 Â by	 Â Integration	 Â Status	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
                                                          in	 Â 2000	 Â Post	 Â Separating	 Â Policy	 Â Implementation	 Â 
                                                                                                                      Not	 Â 
              	 Â 	 Â                                                                                                                                  Integrated	 Â 
                                                                                                                  integrated	 Â                                                               Difference	 Â 
              	 Â                                                                                                                                        in	 Â 2000	 Â 
                                                                                                                    in	 Â 2000	 Â 
              Panel	 Â A:	 Â Office	 Â Visit	 Â Characteristics	 Â 
                                                                                                                                        	 Â                               	 Â                                        	 Â 
                                                               Patient	 Â is	 Â female	 Â 	 Â                           0.56	 Â 	 Â                           0.58	 Â 	 Â                                -Â­â€0.02	 Â 

                                                                           Patient	 Â age	 Â                           35.06	 Â 	 Â                          29.65	 Â 	 Â                        5.40***	 Â 

                                                          Respiratory	 Â illness	 Â 	 Â                                 0.40	 Â 	 Â                           0.45	 Â 	 Â                                -Â­â€0.05	 Â 

                                                   Any	 Â drug	 Â prescription	 Â 	 Â                                   0.98	 Â 	 Â                           0.98	 Â 	 Â                                    0	 Â 
                                                     Antacids/absorbents	 Â 
                                                                                                                        0.20	 Â 	 Â                           0.18	 Â 	 Â                                 0.02	 Â 
                                                              prescribed	 Â 	 Â 
                                  Anti-Â­â€inflammatory	 Â prescribed	 Â 	 Â                                              0.15	 Â 	 Â                           0.15	 Â 	 Â                                    0	 Â 
                                               Analgesics/Antipyretics	 Â 
                                                                                                                        0.12	 Â 	 Â                           0.11	 Â 	 Â                                 0.01	 Â 
                                                           prescribed	 Â 	 Â 
                                                Expectorant	 Â prescribed	 Â 	 Â                                        0.04	 Â 	 Â                           0.04	 Â 	 Â                                    0	 Â 

                                                          Drug	 Â expenditures	 Â                                      88.91	 Â 	 Â                          86.46	 Â 	 Â                                 2.45	 Â 

                                                Diagnostic	 Â test	 Â ordered	 Â 	 Â                                    0.03	 Â 	 Â                           0.03	 Â 	 Â                                 0.00	 Â 

                                     Diagnostic	 Â test	 Â expenditures	 Â 	 Â                                       229.06	 Â 	 Â                         251.09	 Â 	 Â                            -Â­â€22.03	 Â 

                                Physician	 Â service	 Â expenditures	 Â 	 Â                                          248.89	 Â 	 Â                         236.18	 Â 	 Â                                 12.71	 Â 

                                                          Total	 Â expenditures	 Â                                   384.40	 Â 	 Â                         364.34	 Â 	 Â                                 20.06	 Â 

                                              Number	 Â of	 Â observations	 Â                                        41,896	 Â 	 Â                         24,106	 Â 	 Â 
                                                                                                                                                                                                              	 Â 
              Panel	 Â B:	 Â Clinic	 Â characteristics	 Â 
                                                                                                                               	 Â                                 	 Â                                        	 Â 
                                         Monthly	 Â practice	 Â volume	 Â 
                         	 Â                                                                                       1,265.11	 Â 	 Â                       2,121.52	 Â 	 Â                     -Â­â€856.41***	 Â 
                                                                 (visits)	 Â 
                                        Monthly	 Â revenues	 Â (in	 Â 1000	 Â 
                                                                                                                     637.86	 Â 	 Â                         767.82	 Â 	 Â                      -Â­â€129.96**	 Â 	 Â 
                                                                      NT$)	 Â 
                                              Number	 Â of	 Â observations	 Â                                          3,420	 Â 	 Â                          2,128	 Â 	 Â                                1,298	 Â 	 Â 

              Notes:	 Â The	 Â sample	 Â is	 Â visits	 Â to	 Â clinics	 Â not	 Â integrated	 Â at	 Â baseline	 Â by	 Â patients	 Â between	 Â older	 Â 
              than	 Â 3	 Â and	 Â younger	 Â than	 Â 60	 Â for	 Â diagnoses	 Â covered	 Â under	 Â the	 Â separating	 Â policy.	 Â Integrated	 Â 
              is	 Â defined	 Â as	 Â having	 Â an	 Â onsite	 Â pharmacy	 Â in	 Â 2000	 Â after	 Â to	 Â the	 Â implementation	 Â of	 Â the	 Â 
              separating	 Â policy	 Â in	 Â township	 Â in	 Â which	 Â the	 Â clinic	 Â is	 Â located.	 Â 	 Â Expenditures	 Â are	 Â reported	 Â in	 Â 
              1997	 Â New	 Â Taiwanese	 Â Dollars.	 Â Expenditures	 Â for	 Â drugs	 Â and	 Â diagnostic	 Â tests	 Â are	 Â conditional	 Â 
              on	 Â positive	 Â expenditure.	 Â Statistical	 Â significance	 Â levels	 Â for	 Â tests	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â 
              the	 Â difference	 Â in	 Â means	 Â is	 Â zero	 Â are	 Â marked	 Â as	 Â ***	 Â indicating	 Â p	 Â <	 Â 0.01	 Â and	 Â **	 Â indicating	 Â p	 Â <	 Â 
              0.05.	 Â The	 Â hypothesis	 Â tests	 Â are	 Â conducted	 Â clustering	 Â standard	 Â errors	 Â at	 Â the	 Â township	 Â level.	 Â 	 Â 
       	 Â 
                                                                                                                                      	 Â 
                                                                                                                                      	 Â 
                                                                                                                        	 Â                                                                       	 Â 


                                                                                                                               27
                                                                                                                                            	 Â 


              Table	 Â 4:	 Â Impact	 Â of	 Â the	 Â Separating	 Â Policy	 Â on	 Â Probability	 Â a	 Â Clinic	 Â Integrates	 Â 
	 Â 
       	 Â                                                                    Model	 Â (1)	 Â                  Model	 Â (2)	 Â 

                   Treatment	 Â                                               0.660***	 Â                       0.090**	 Â 
                   	 Â                                                        (0.011)	 Â                        (0.043)	 Â 

                   Treat	 Â Ã—	 Â D25-Â­â€50%tileâ€ 	 Â                                     	 Â                     0.196***	 Â 
                   	 Â                                                                 	 Â                     (0.021)	 Â 

                   Treatment	 Â Ã—	 Â D50-Â­â€75%tileâ€ 	 Â                                 	 Â                     0.430***	 Â 
                   	 Â                                                                 	 Â                     (0.021)	 Â 

                   Treatment	 Â Ã—	 Â D75-Â­â€100%tileâ€ 	 Â                                	 Â                     0.887***	 Â 
                   	 Â                                                                 	 Â                     (0.020)	 Â 

                   Number	 Â of	 Â observations	 Â                                 3,916	 Â                       3,916	 Â 

                   R-Â­â€squared	 Â                                                  0.56	 Â                         0.72	 Â 

       Notes:	 Â  The	 Â  coefficient	 Â  and	 Â  standard	 Â  error	 Â  are	 Â  the	 Â  difference	 Â  in	 Â  difference	 Â 
       estimate	 Â  of	 Â  the	 Â  effect	 Â  of	 Â  the	 Â  separating	 Â  policy	 Â  on	 Â  the	 Â  probability	 Â  a	 Â  clinic	 Â 
       integrates	 Â  controlling	 Â  for	 Â  clinic	 Â  fixed	 Â  effects	 Â  and	 Â  quarter-Â­â€year	 Â  effects.	 Â  The	 Â 
       unit	 Â of	 Â observation	 Â is	 Â the	 Â clinic	 Â and	 Â the	 Â sample	 Â is	 Â that	 Â set	 Â of	 Â clinics	 Â that	 Â were	 Â 
       not	 Â  integrated	 Â  prior	 Â  to	 Â  the	 Â  implementation	 Â  of	 Â  the	 Â  separating	 Â  policy.	 Â  The	 Â 
       standard	 Â  errors	 Â  are	 Â  clustered	 Â  at	 Â  the	 Â  township	 Â  level.	 Â  Statistical	 Â  significance	 Â 
       levels	 Â for	 Â tests	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â the	 Â coefficient	 Â estimate	 Â is	 Â zero	 Â are	 Â 
       marked	 Â as	 Â ***	 Â indicating	 Â p	 Â <	 Â 0.01	 Â and	 Â **	 Â indicating	 Â p	 Â <	 Â 0.05.	 Â 
                                                                       	 Â 
	 Â 
	 Â 
	 Â 
	 Â 
	 Â 
	 Â 
	 Â 
	 Â 
	 Â 




                                                                              28
                                                                                                                                                                                                                                       	 Â 


                                                                Table	 Â 5:	 Â Impact	 Â of	 Â Separating	 Â Policy	 Â on	 Â Clinics	 Â by	 Â Integration	 Â Choice	 Â 
          	 Â                                            Any	 Â                   Log	 Â drug	 Â               Any	 Â diagnostic	 Â            Log	 Â diagnostic	 Â            Log	 Â physician	 Â               Log	 Â total	 Â 
          	 Â                                        Prescription	 Â            expenditures	 Â                       tests	 Â                  expenditures	 Â                expenditures	 Â                 expenditures	 Â 
     Panel	 Â A:	 Â Triple	 Â Differences	 Â 	 Â 
                      (a)	 Â Treatment	 Â              -Â­â€0.021***	 Â                -Â­â€0.049**	 Â                  0.005***	 Â                        -Â­â€0.020	 Â                    -Â­â€0.000	 Â                  -Â­â€0.018***	 Â 
                                      	 Â                 (0.002)	 Â                    (0.022)	 Â                   (0.002)	 Â                       (0.025)	 Â                     (0.002)	 Â                       (0.006)	 Â 
  (b)	 Â Treatment	 Â Ã—	 Â Pharmacy	 Â                 0.019***	 Â                     0.030	 Â                        -Â­â€0.004	 Â                     -Â­â€0.010	 Â                      0.000	 Â                     0.014***	 Â 
                                   	 Â                  (0.003)	 Â                    (0.018)	 Â                      (0.002)	 Â                      (0.024)	 Â                     (0.002)	 Â                       (0.005)	 Â 
                               (a)	 Â +	 Â (b)	 Â         -Â­â€0.002	 Â                  -Â­â€0.018	 Â                     0.001	 Â                        -Â­â€0.009	 Â                      0.000	 Â                       -Â­â€0.004	 Â 
                                              	 Â        (0.002)	 Â                   (0.017)	 Â                      (0.002)	 Â                      (0.025)	 Â                     (0.002)	 Â                       (0.005)	 Â 
                       Observations	 Â                  871,319	 Â 	 Â               641,627	 Â 	 Â                  871,319	 Â 	 Â                    35,030	 Â 	 Â                 871,319	 Â 	 Â                 673,899	 Â 	 Â 
  Panel	 Â B:	 Â Instrumental	 Â Variable	 Â Triple	 Â Differences	 Â                                                      	 Â 	 Â                          	 Â 	 Â                        	 Â 	 Â                        	 Â 	 Â 
                      (a)	 Â Treatment	 Â             -Â­â€0.0270***	 Â                -Â­â€0.049**	 Â                  0.006***	 Â                        -Â­â€0.037	 Â                    0.004	 Â                    -Â­â€0.0180***	 Â 
                                      	 Â                 (0.003)	 Â                    (0.025)	 Â                   (0.002)	 Â                       (0.033)	 Â                     (0.003)	 Â                       (0.007)	 Â 
  (b)	 Â Treatment	 Â Ã—	 Â Pharmacy	 Â                 0.033***	 Â                   0.106**	 Â                        -Â­â€0.004	 Â                     0.019	 Â                       -Â­â€0.004	 Â                   0.041***	 Â 
                                   	 Â                  (0.005)	 Â                   (0.046)	 Â                       (0.004)	 Â                      (0.058)	 Â                     (0.006)	 Â                     (0.013)	 Â 
                               (a)	 Â +	 Â (b)	 Â         0.006	 Â                   0.058**	 Â                        0.002	 Â                        -Â­â€0.179	 Â                    -Â­â€0.001	 Â                  0.023***	 Â 
                                              	 Â        (0.003)	 Â                  (0.032)	 Â                       (0.003)	 Â                      (0.040)	 Â                     (0.004)	 Â                     (0.009)	 Â 
                      Observations	 Â            751,004	 Â 	 Â              543,114	 Â 	 Â                          751,004	 Â 	 Â                   27,836	 Â 	 Â                  751,004	 Â 	 Â                 569,665	 Â 	 Â 
  Panel	 Â C:	 Â Falsification	 Â Tests	 Â (Sample	 Â of	 Â patients	 Â exempt	 Â from	 Â policy)	 Â                                                      	 Â 	 Â                          	 Â 	 Â                        	 Â 	 Â 
                     (a)	 Â Treatment	 Â        -Â­â€0.007**	 Â                 -Â­â€0.002	 Â                              -Â­â€0.003	 Â                     0.094	 Â                       -Â­â€0.002	 Â                    -Â­â€0.009	 Â 
                                       	 Â         (0.003)	 Â                (0.029)	 Â                               (0.003)	 Â                      (0.099)	 Â                     (0.004)	 Â                     (0.000)	 Â 
  (b)	 Â Treatment	 Â Ã—	 Â Pharmacy	 Â                  0.007**	 Â                     0.001	 Â                        0.001	 Â                        -Â­â€0.162	 Â                      0.001	 Â                       0.011	 Â 
                                   	 Â                  (0.003)	 Â                    (0.028)	 Â                      (0.003)	 Â                      (0.093)	 Â                     (0.005)	 Â                     (0.009)	 Â 
                               (a)	 Â +	 Â (b)	 Â         -Â­â€0.000	 Â                  -Â­â€0.001	 Â                     -Â­â€0.001	 Â                     -Â­â€0.068	 Â                    -Â­â€0.001	 Â                      0.003	 Â 
                                              	 Â        (0.003)	 Â                   (0.030)	 Â                      (0.003)	 Â                      (0.095)	 Â                     (0.005)	 Â                     (0.010)	 Â 
                        Observations	 Â                    135,605	 Â 	 Â               97,376	 Â 	 Â                   135,605	 Â 	 Â                     4,226	 Â 	 Â                    135,605	 Â 	 Â                101,203	 Â 	 Â 
Notes:	 Â Treatment	 Â (a)	 Â is	 Â the	 Â estimated	 Â impact	 Â of	 Â the	 Â separating	 Â policy	 Â on	 Â clinics	 Â that	 Â did	 Â not	 Â integrate	 Â and	 Â (a)	 Â +(b)	 Â is	 Â the	 Â estimate	 Â of	 Â the	 Â separating	 Â 
policy	 Â on	 Â clinics	 Â that	 Â choose	 Â to	 Â integrate.	 Â 	 Â Panel	 Â A	 Â reports	 Â the	 Â triple	 Â difference	 Â estimate	 Â of	 Â the	 Â effect	 Â of	 Â the	 Â separating	 Â policy	 Â on	 Â the	 Â dependent	 Â 
variable	 Â listed	 Â at	 Â the	 Â top	 Â of	 Â the	 Â column	 Â controlling	 Â for	 Â physician	 Â fixed	 Â effects,	 Â quarter-Â­â€year	 Â for	 Â each	 Â township	 Â fixed	 Â effects,	 Â diagnosis	 Â fixed	 Â effects,	 Â and	 Â 
patient	 Â age	 Â and	 Â sex	 Â for	 Â the	 Â sample	 Â of	 Â patients	 Â covered	 Â by	 Â the	 Â separating	 Â policy.	 Â Panel	 Â B	 Â reports	 Â the	 Â IV	 Â triple	 Â difference	 Â estimates	 Â uses	 Â baseline	 Â patient	 Â 
volume	 Â as	 Â the	 Â instrument	 Â for	 Â integration	 Â for	 Â the	 Â sample.	 Â 	 Â Panel	 Â C	 Â reports	 Â the	 Â triple	 Â difference	 Â estimates	 Â for	 Â the	 Â sample	 Â of	 Â patients	 Â exempt	 Â from	 Â the	 Â 
separating	 Â policy.	 Â The	 Â standard	 Â errors	 Â are	 Â clustered	 Â at	 Â the	 Â physician	 Â level	 Â and	 Â ***	 Â p<0.01,	 Â **	 Â p<0.05	 Â for	 Â the	 Â test	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â the	 Â 
coefficient	 Â is	 Â different	 Â from	 Â zero.	 Â 	 Â 


                                                                                                                     29
                                                                                                                                                                           	 Â 


              Table	 Â 6:	 Â Triple	 Â Difference	 Â Estimate	 Â of	 Â Policy	 Â Impact	 Â on	 Â Medication	 Â Adherence	 Â Measured	 Â by	 Â the	 Â 
                                   Proportion	 Â of	 Â Days	 Â Having	 Â Prescribed	 Â Medication	 Â in	 Â Last	 Â 90	 Â Days.	 Â 
	 Â 
                                                                                                                                      Hypertension	 Â 	 Â 
                                                                                     Diabetes	 Â 
       	 Â                                                                                                                             (>	 Â 12	 Â visits)	 Â 
                                       (a)	 Â Treatment	 Â 	 Â                         -Â­â€0.018	 Â                                           -Â­â€0.014	 Â 
                                                       	 Â                            (0.018)	 Â                                            (0.013)	 Â 

                    (b)	 Â Treatment	 Â 	 Â Ã—	 Â pharmacy	 Â                           0.002	 Â                                              0.018	 Â 
                                                         	 Â                          (0.016)	 Â                                            (0.011)	 Â 

                                                (a)	 Â +	 Â (b)	 Â                     0.006	 Â                                              0.005	 Â 
                                                               	 Â                    (0.016)	 Â                                            (0.009)	 Â 

                                        Observations	 Â                                86,915	 Â                                           103,933	 Â 
                               Number	 Â of	 Â patients	 Â                              8,575	 Â                                              3,885	 Â 
                                 Number	 Â of	 Â Clinics	 Â                             2,143	 Â                                              3,071	 Â 
                       1997	 Â baseline	 Â mean	 Â PDC	 Â                                0.61	 Â                                               0.57	 Â 
       Notes:	 Â  Treatment	 Â  is	 Â  the	 Â  triple	 Â  difference	 Â  estimate	 Â  of	 Â  the	 Â  effect	 Â  of	 Â  the	 Â  separating	 Â  policy	 Â  on	 Â  the	 Â 
       proportion	 Â  of	 Â  days	 Â  the	 Â  patient	 Â  has	 Â  prescribed	 Â  medication	 Â  for	 Â  their	 Â  illness	 Â  controlling	 Â  for	 Â  physician	 Â 
       fixed	 Â effects,	 Â quarter-Â­â€year	 Â for	 Â each	 Â township	 Â fixed	 Â effects,	 Â diagnosis	 Â fixed	 Â effects,	 Â and	 Â patient	 Â age	 Â and	 Â 
       sex.	 Â The	 Â standard	 Â errors	 Â are	 Â clustered	 Â at	 Â the	 Â physician	 Â level	 Â and	 Â ***	 Â p<0.01,	 Â **	 Â p<0.05	 Â for	 Â the	 Â test	 Â of	 Â 
       the	 Â null	 Â hypothesis	 Â that	 Â the	 Â coefficient	 Â is	 Â different	 Â from	 Â zero.	 Â Diabetes	 Â includes	 Â all	 Â diagnoses	 Â with	 Â an	 Â 
       ICD9CM	 Â code	 Â of	 Â 249	 Â or	 Â 250.	 Â Hypertension	 Â includes	 Â all	 Â diagnoses	 Â with	 Â an	 Â ICD9CM	 Â code	 Â of	 Â 401-Â­â€405.	 Â 	 Â 
	 Â 
	 Â                                                            	 Â 




                                                                                             30
                                                                                                                                                                                                                                                                                        	 Â 


                                 Table	 Â 7:	 Â Effects	 Â of	 Â the	 Â Separating	 Â Policy	 Â on	 Â Adverse	 Â Health	 Â Events	 Â 
                                                                        Panel	 Â A:	 Â Reduced	 Â Form	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â  Panel	 Â B:	 Â By	 Â Integration	 Â Status	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
       	 Â 
                                                                       Difference	 Â in	 Â Differences	 Â                                                                                      Triple	 Â Differences	 Â 
       	 Â 	 Â                                                           ER	 Â visit	 Â                                 Hospitalized	 Â                           	 Â              ER	 Â visit	 Â                             Hospitalized	 Â 
       Panel	 Â A:	 Â Patients	 Â with	 Â Acute	 Â Respiratory	 Â Infections,	 Â 30-Â­â€day	 Â follow-Â­â€up	 Â (N	 Â =	 Â 261,400)	 Â 
                             (a)	 Â Treatment	 Â           -Â­â€0.0001	 Â             0.0001	 Â          	 Â             0.0005	 Â                                                                                                     0.0004	 Â 
                                                                	 Â    (0.0002)	 Â                                        (0.0006)	 Â                             	 Â            (0.0004)	 Â                                        (0.0012)	 Â 
                  (b)	 Â Treatment	 Â Ã—	 Â Pharmacy	 Â                              	 Â                                               	 Â                         	 Â            	 Â -Â­â€0.0008	 Â                                    -Â­â€0.0001	 Â 
                                                                	 Â                 	 Â                                               	 Â                         	 Â            (0.0006)	 Â                                        (0.0012)	 Â 
                                           (a)	 Â +	 Â (b)	 Â                       	 Â                                               	 Â                         	 Â             -Â­â€0.0003	 Â                                       0.0003	 Â 
                                                                	 Â                 	 Â                                               	 Â                         	 Â            (0.0002)	 Â                                        (0.0008)	 Â 
                          1997	 Â baseline	 Â mean	 Â                     0.0001	 Â                                          0.003	 Â                             	 Â             0.00013	 Â                                          0.0026	 Â 
       Panel	 Â B:	 Â Patients	 Â with	 Â Diabetes	 Â Mellitus,	 Â 360-Â­â€day	 Â follow-Â­â€up	 Â 	 Â (N	 Â 	 Â =	 Â 14,001)	 Â 
                             (a)	 Â Treatment	 Â 	 Â       0.00003	 Â                -Â­â€0.00000	 Â                  	 Â       0.0005	 Â                                                                                              	 Â 0.0113	 Â 
                                                 	 Â     (0.00146)	 Â                   (0.022)	 Â                  	 Â    (0.0016)	 Â                                                                                              (0.0301)	 Â 

                                   (a)	 Â Treatment	 Â                              	 Â                                               	 Â                         	 Â             -Â­â€0.0006	 Â                                       -Â­â€0.0138	 Â 
                                                   	 Â                              	 Â                                               	 Â                         	 Â            (0.0016)	 Â                                        (0.0311)	 Â 
                                          (a)	 Â +	 Â (b)	 Â                        	 Â                          	 Â                  	 Â                         	 Â             -Â­â€0.0001	 Â                                       -Â­â€0.0024	 Â 
                                                                	 Â 




                                                                	 Â                 	 Â                                               	 Â                         	 Â            (0.0016)	 Â                                        (0.0242)	 Â 
                          1997	 Â baseline	 Â mean	 Â                   0.00040	 Â                                        0.16000	 Â                              	 Â           0.000408	 Â                                               0.16	 Â 
       Panel	 Â C:	 Â Patients	 Â with	 Â Hypertension	 Â 360-Â­â€day	 Â follow-Â­â€up	 Â (N	 Â =	 Â 35,895)	 Â 
                                   (a)	 Â Treatment	 Â                  -Â­â€0.0017	 Â                                       -Â­â€0.0063	 Â                           	 Â             -Â­â€0.0014	 Â                                       -Â­â€0.0217	 Â 
                                                   	 Â                 (0.0022)	 Â                                        (0.0099)	 Â                             	 Â            (0.0025)	 Â                                        (0.0155)	 Â 
                  (b)	 Â Treatment	 Â Ã—	 Â Pharmacy	 Â                              	 Â                                               	 Â                         	 Â             -Â­â€0.0005	 Â                                       0.0177	 Â 
                                                                	 Â                 	 Â                                               	 Â                         	 Â            (0.0017)	 Â                                        (0.0153)	 Â 
                                           (a)	 Â +	 Â (b)	 Â                       	 Â                                               	 Â                         	 Â             -Â­â€0.0018	 Â                                       -Â­â€0.0041	 Â 
                                                                	 Â                 	 Â                                               	 Â                         	 Â            (0.0023)	 Â                                        (0.0108)	 Â 
                          1997	 Â baseline	 Â mean	 Â 	 Â                 0.0024	 Â                                        0.1480	 Â                              	 Â               0.0024	 Â                                         0.1504	 Â 

       Notes:	 Â Treatment	 Â is	 Â the	 Â triple	 Â difference	 Â estimate	 Â of	 Â the	 Â effect	 Â of	 Â the	 Â separating	 Â policy	 Â on	 Â the	 Â 
       probability	 Â having	 Â an	 Â adverse	 Â event	 Â for	 Â the	 Â sample	 Â of	 Â patient	 Â with	 Â the	 Â illness	 Â controlling	 Â for	 Â 
       physician	 Â fixed	 Â effects,	 Â quarter-Â­â€year	 Â for	 Â each	 Â municipality	 Â fixed	 Â effects,	 Â diagnosis	 Â fixed	 Â effects,	 Â and	 Â 
       patient	 Â age	 Â and	 Â sex.	 Â The	 Â standard	 Â errors	 Â are	 Â clustered	 Â at	 Â the	 Â physician	 Â level	 Â and	 Â ***	 Â p<0.01,	 Â **	 Â 
       p<0.05	 Â for	 Â the	 Â test	 Â of	 Â the	 Â null	 Â hypothesis	 Â that	 Â the	 Â coefficient	 Â is	 Â different	 Â from	 Â zero.	 Â Diabetes	 Â 
       includes	 Â all	 Â diagnoses	 Â with	 Â an	 Â ICD9CM	 Â code	 Â of	 Â 249	 Â or	 Â 250.	 Â Hypertension	 Â includes	 Â all	 Â diagnoses	 Â 
       with	 Â an	 Â ICD9CM	 Â code	 Â of	 Â 401-Â­â€405.	 Â Acute	 Â Respiratory	 Â Infections	 Â include	 Â all	 Â diagnoses	 Â with	 Â an	 Â 
       ICD9CM	 Â code	 Â of	 Â 460-Â­â€478.	 Â 	 Â 
	 Â 




                                                                                                                          31
                                       	 Â 


              Figure	 Â 1	 Â 




                                	 Â 
	 Â    	 Â 




                        32
                                        	 Â 


              Figure	 Â 2	 Â 




                                 	 Â 
                     	 Â 
	 Â    	 Â 




                            33
                                       	 Â 


              Figure	 Â 3	 Â 




                                	 Â 
	 Â    	 Â 




                        34
                                           	 Â 


              Figure	 Â 4	 Â 	 Â 




                                    	 Â 
                      	 Â 
                      	 Â 
                      	 Â 
                      	 Â 
	 Â    	 Â 




                             35
                                        	 Â 


              Figure	 Â 5	 Â 




                                 	 Â 
                     	 Â 
	 Â    	 Â 




                            36
                                	 Â 


       Figure	 Â 6	 Â 




                         	 Â 
	 Â 




                 37
                                                                                                                                                                                                                                                                                                                                                                                	 Â 


                                                                                                                              APPENDIX	 Â TABLES	 Â 
                                                                                                                                     	 Â 
                                           Table	 Â A1:	 Â P-Â­â€Values	 Â for	 Â tests	 Â equality	 Â of	 Â pre-Â­â€intervention	 Â trends	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
                                                                for	 Â treatment	 Â &	 Â comparison	 Â groups	 Â 
   Not	 Â Integrated	 Â prior	 Â to	 Â             	 Â                                                              Log	 Â drug	 Â                                            Diagnostic	 Â                                       Log	 Â diagnostic	 Â                                        Log	 Â total	 Â 
                                                              Prescription	 Â 
     policy	 Â Ã—	 Â Trend	 Â Ã—	 Â â€¦	 Â                                                                            expenditures	 Â                                                tests	 Â                                         expenditures	 Â 	 Â                                       expenditures	 Â 
          Municipality	 Â 1	 Â                     	 Â                  0.017	 Â                                             0.239	 Â                                                0.149	 Â                                                  -Â­â€0.028	 Â                                             0.186	 Â 
                	 Â                                	 Â                 (0.016)	 Â                                           (0.193)	 Â                                              (0.091)	 Â                                                (0.018)	 Â                                              (0.157)	 Â 
          Municipality	 Â 2	 Â                     	 Â                  -Â­â€0.079	 Â                                          -Â­â€0.016	 Â                                             -Â­â€0.153	 Â                                               0.493	 Â                                                -Â­â€0.477	 Â 
                	 Â                                	 Â                 (0.067)	 Â                                           (0.164)	 Â                                              (0.108)	 Â                                                (0.500)	 Â                                              (0.297)	 Â 
          Municipality	 Â 3	 Â                     	 Â                  -Â­â€0.001	 Â                                          -Â­â€0.001	 Â                                             0.013	 Â                                                  -Â­â€0.025	 Â                                             0.001	 Â 
                	 Â                                	 Â                 (0.001)	 Â                                           (0.006)	 Â                                              (0.008)	 Â                                                (0.040)	 Â                                              (0.008)	 Â 
          Municipality	 Â 4	 Â                     	 Â                0.000	 Â                                               0.005	 Â                                              0.0013	 Â                                                   -Â­â€0.020	 Â                                             0.000	 Â 
                	 Â                                	 Â               (0.0017)	 Â                                            (0.004)	 Â                                            (0.0026)	 Â                                                 (0.022)	 Â                                              (0.005)	 Â 
          Municipality	 Â 5	 Â                     	 Â                 -Â­â€0.003*	 Â                                          0.005	 Â                                                -Â­â€0.003	 Â                                               -Â­â€0.014	 Â                                             -Â­â€0.000	 Â 
                	 Â                                	 Â                 (0.001)	 Â                                           (0.003)	 Â                                              (0.003)	 Â                                                (0.021)	 Â                                              (0.004)	 Â 
          	 Â Municipality	 Â 6	 Â                 	 Â                  0.000	 Â                                             0.001	 Â                                                -Â­â€0.003	 Â                                               -Â­â€0.008	 Â                                             -Â­â€0.001	 Â 
                    	 Â                            	 Â                 (0.000)	 Â                                           (0.002)	 Â                                              (0.003)	 Â                                                (0.018)	 Â                                              (0.003)	 Â 
         	 Â 	 Â Municipality	 Â 7	 Â              	 Â                  -Â­â€0.001	 Â                                       0.0150*	 Â                                                 0.007	 Â                                                  0.002	 Â                                                0.015	 Â 
                       	 Â                         	 Â                 (0.002)	 Â                                         (0.007)	 Â                                                (0.007)	 Â                                                (0.041)	 Â                                              (0.009)	 Â 
          	 Â Municipality	 Â 8	 Â                 	 Â                  0.000	 Â                                             0.000	 Â                                                0.002	 Â                                                  0.000	 Â                                                -Â­â€0.001	 Â 
                    	 Â                            	 Â                 (0.000)	 Â                                           (0.002)	 Â                                              (0.003)	 Â                                                (0.015)	 Â                                              (0.004)	 Â 
          	 Â Municipality	 Â 9	 Â                 	 Â                  -Â­â€0.000	 Â                                          -Â­â€0.002	 Â                                             0.000	 Â                                                  -Â­â€0.017	 Â                                             -Â­â€0.005	 Â 
                    	 Â                            	 Â                 (0.001)	 Â                                           (0.002)	 Â                                              (0.002)	 Â                                                (0.015)	 Â                                              (0.003)	 Â 
        	 Â 	 Â Municipality	 Â 10	 Â              	 Â                 -Â­â€0.003*	 Â                                        -Â­â€0.0251	 Â                                              0.008	 Â                                                0.090*	 Â                                                 -Â­â€0.010	 Â 
                      	 Â                          	 Â                 (0.001)	 Â                                         (0.0155)	 Â                                               (0.007)	 Â                                               (0.038)	 Â                                               (0.017)	 Â 
        	 Â 	 Â Municipality	 Â 11	 Â              	 Â                  0.001	 Â                                             -Â­â€0.003	 Â                                             -Â­â€0.000	 Â                                               -Â­â€0.018	 Â                                           -Â­â€0.011*	 Â 
                      	 Â                          	 Â                 (0.001)	 Â                                           (0.004)	 Â                                              (0.004)	 Â                                                (0.023)	 Â                                             (0.004)	 Â 
         	 Â Municipality	 Â 12	 Â                 	 Â                  -Â­â€0.001	 Â                                          0.002	 Â                                                -Â­â€0.003	 Â                                               0.016	 Â                                                0.000	 Â 
                    	 Â                            	 Â                 (0.001)	 Â                                           (0.003)	 Â                                              (0.003)	 Â                                                (0.021)	 Â                                              (0.004)	 Â 
         	 Â Municipality	 Â 13	 Â                 	 Â                  0.000	 Â                                             -Â­â€0.000	 Â                                             -Â­â€0.003	 Â                                               -Â­â€0.020	 Â                                             -Â­â€0.002	 Â 
                    	 Â                            	 Â                 (0.001)	 Â                                           (0.005)	 Â                                              (0.005)	 Â                                                (0.033)	 Â                                              (0.008)	 Â 
         	 Â Municipality	 Â 14	 Â                 	 Â                  0.001	 Â                                             0.006	 Â                                                0.008	 Â                                                  -Â­â€0.005	 Â                                             0.008	 Â 
                    	 Â                            	 Â                 (0.003)	 Â                                           (0.007)	 Â                                              (0.005)	 Â                                                (0.050)	 Â                                              (0.008)	 Â 
         	 Â Municipality	 Â 15	 Â                 	 Â                  0.001	 Â                                             -Â­â€0.023	 Â                                             0.013	 Â                                                  -Â­â€0.027	 Â                                             -Â­â€0.020	 Â 
                    	 Â                            	 Â                 (0.003)	 Â                                           (0.013)	 Â                                              (0.010)	 Â                                                (0.086)	 Â                                              (0.015)	 Â 
         Municipality	 Â 16	 Â                     	 Â                  -Â­â€0.002	 Â                                          -Â­â€0.002	 Â                                             -Â­â€0.009	 Â                                               -Â­â€0.026	 Â                                             -Â­â€0.015	 Â 
                	 Â                                	 Â                 (0.002)	 Â                                           (0.008)	 Â                                              (0.009)	 Â                                                (0.048)	 Â                                              (0.010)	 Â 
         Municipality	 Â 17	 Â                     	 Â                  0.000	 Â                                             0.001	 Â                                              -Â­â€0.007*	 Â                                                -Â­â€0.009	 Â                                             0.000	 Â 
                	 Â                                	 Â                 (0.001)	 Â                                           (0.003)	 Â                                             (0.004)	 Â                                                 (0.015)	 Â                                              (0.003)	 Â 
         	 Â Municipality	 Â 18	 Â                 	 Â                  0.000	 Â                                           -Â­â€0.010*	 Â                                              -Â­â€0.004	 Â                                               0.022	 Â                                                -Â­â€0.006	 Â 
                    	 Â                            	 Â                 (0.001)	 Â                                          (0.005)	 Â                                               (0.005)	 Â                                                (0.031)	 Â                                              (0.006)	 Â 
         F	 Â stat	 Â for	 Â joint	 Â 
                                                   	 Â                      1.00	 Â                                             1.52	 Â                                                 1.29	 Â                                                   0.84	 Â                                                 1.22	 Â 
          significance	 Â 
       Prob	 Â >	 Â F	 Â (p-Â­â€value)	 Â            	 Â                      0.45	 Â                                             0.07	 Â                                                 0.18	 Â                                                   0.66	 Â                                                 0.23	 Â 
           Observations	 Â                         	 Â                265,070	 Â                                          257,341	 Â                                              265,070	 Â                                                  60,492	 Â                                              257,376	 Â 

  Notes:	 Â The	 Â coefficients	 Â and	 Â standard	 Â error	 Â are	 Â from	 Â regressions	 Â on	 Â the	 Â dependent	 Â variable	 Â listed	 Â at	 Â the	 Â top	 Â of	 Â the	 Â column	 Â 
  controlling	 Â for	 Â physician	 Â fixed	 Â effects,	 Â quarter-Â­â€year	 Â for	 Â each	 Â municipality	 Â fixed	 Â effects,	 Â diagnosis	 Â fixed	 Â effects,	 Â and	 Â patient	 Â 
 age	 Â and	 Â sex.	 Â The	 Â sample	 Â is	 Â visits	 Â to	 Â clinics	 Â prior	 Â to	 Â the	 Â implementation	 Â of	 Â the	 Â separating	 Â policy	 Â in	 Â the	 Â township	 Â in	 Â which	 Â the	 Â 
                       clinic	 Â is	 Â located.	 Â The	 Â standard	 Â errors	 Â are	 Â clustered	 Â at	 Â the	 Â township	 Â level	 Â and	 Â ***	 Â p<0.01,	 Â **	 Â p<0.05.	 Â 
                                                                                                                                                  	 Â 
                                                                                                                                                                      	 Â 
	 Â                                                                                      	 Â 




                                                                                                                                                                              38
                                                                                                                                                                                                                                                                                                              	 Â 


                    Table	 Â A2:	 Â P-Â­â€Values	 Â for	 Â test	 Â of	 Â equality	 Â of	 Â pre-Â­â€intervention	 Â trends	 Â for	 Â clinics	 Â that	 Â hire	 Â and	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 	 Â 
                                         do	 Â not	 Â hire	 Â an	 Â onsite	 Â pharmacy	 Â in	 Â the	 Â post	 Â intervention	 Â period	 Â 
                                                                  	 Â                                                         Log	 Â drug	 Â                                                                            Log	 Â diagnostic	 Â                              Log	 Â total	 Â 
       Integrated	 Â post	 Â policy	 Â Ã—	 Â                                   Prescription	 Â                                                                           Diagnostic	 Â test	 Â 
              Trend	 Â Ã—	 Â â€¦	 Â                                                                                            expenditures	 Â                                                                             expenditures	 Â                                 expenditures	 Â 

               Municipality	 Â 1	 Â                               	 Â                 0.179	 Â                                     -Â­â€0.0225	 Â                                    -Â­â€0.281	 Â                                  -Â­â€0.0679	 Â                                  0.00955	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                   (0.0411)	 Â                                     (0.185)	 Â                                     (0.102)	 Â                                   (0.0222)	 Â 

               Municipality	 Â 2	 Â                               	 Â                 0.181	 Â                                     -Â­â€0.0284	 Â                                    -Â­â€0.282	 Â                                  -Â­â€0.0457	 Â                                   0.0142	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                   (0.0426)	 Â                                     (0.185)	 Â                                   (0.0922)	 Â                                    (0.0220)	 Â 

               Municipality	 Â 3	 Â                               	 Â                 0.181	 Â                                     -Â­â€0.0128	 Â                                    -Â­â€0.281	 Â                                  -Â­â€0.0139	 Â                                   0.0157	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                   (0.0384)	 Â                                     (0.185)	 Â                                   (0.0724)	 Â                                    (0.0219)	 Â 

               Municipality	 Â 4	 Â                               	 Â                 0.181	 Â                                     -Â­â€0.0261	 Â                                    -Â­â€0.283	 Â                                  -Â­â€0.0605	 Â                                  0.00791	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                   (0.0310)	 Â                                     (0.185)	 Â                                   (0.0761)	 Â                                    (0.0220)	 Â 

               Municipality	 Â 5	 Â                               	 Â                 0.180	 Â                                    -Â­â€0.00387	 Â                                    -Â­â€0.274	 Â                                  -Â­â€0.120	 Â                                    0.0113	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                    (0.0578)	 Â                                    (0.185)	 Â                                   (0.0921)	 Â                                    (0.0219)	 Â 

               	 Â Municipality	 Â 6	 Â                           	 Â                 0.179	 Â                                     -Â­â€0.0127	 Â                                    -Â­â€0.277	 Â                                 -Â­â€0.00388	 Â                                  0.00874	 Â 
                         	 Â                                      	 Â                (0.151)	 Â                                   (0.0329)	 Â                                     (0.185)	 Â                                    (0.0693)	 Â                                   (0.0205)	 Â 

              	 Â 	 Â Municipality	 Â 7	 Â                        	 Â                 0.184	 Â                                     -Â­â€0.0244	 Â                                    -Â­â€0.284	 Â                                  -Â­â€0.0213	 Â                                   0.0152	 Â 
                            	 Â                                   	 Â                (0.151)	 Â                                   (0.0284)	 Â                                     (0.185)	 Â                                   (0.0672)	 Â                                    (0.0218)	 Â 

               	 Â Municipality	 Â 8	 Â                           	 Â                 0.187	 Â                                     -Â­â€0.0536	 Â                                    -Â­â€0.284	 Â                                 -Â­â€0.180*	 Â                                    0.0118	 Â 
                         	 Â                                      	 Â                (0.151)	 Â                                   (0.0393)	 Â                                     (0.185)	 Â                                  (0.0795)	 Â                                     (0.0217)	 Â 

               	 Â Municipality	 Â 9	 Â                           	 Â                 0.183	 Â                                     0.0400	 Â                                       -Â­â€0.278	 Â                                  -Â­â€0.0697	 Â                                   0.0135	 Â 
                         	 Â                                      	 Â                (0.151)	 Â                                   (0.0474)	 Â                                     (0.185)	 Â                                   (0.0879)	 Â                                    (0.0218)	 Â 

             	 Â 	 Â Municipality	 Â 10	 Â                        	 Â                 0.183	 Â                                     -Â­â€0.0212	 Â                                    -Â­â€0.280	 Â                                 -Â­â€0.00633	 Â                                   0.0140	 Â 
                           	 Â                                    	 Â                (0.151)	 Â                                   (0.0374)	 Â                                     (0.185)	 Â                                    (0.0756)	 Â                                   (0.0218)	 Â 

             	 Â 	 Â Municipality	 Â 11	 Â                        	 Â                 0.181	 Â                                     -Â­â€0.106	 Â                                     -Â­â€0.282	 Â                                  -Â­â€0.0572	 Â                                  0.00599	 Â 
                           	 Â                                    	 Â                (0.151)	 Â                                   (0.0640)	 Â                                     (0.185)	 Â                                   (0.0960)	 Â                                    (0.0220)	 Â 

             	 Â Municipality	 Â 12	 Â                            	 Â                 0.180	 Â                                     Omitted	 Â                                      -Â­â€0.280	 Â                                  Omitted	 Â                                     0.0233	 Â 
                        	 Â                                       	 Â                (0.151)	 Â                                       	 Â                                         (0.185)	 Â                                       	 Â                                        (0.0247)	 Â 

             	 Â Municipality	 Â 13	 Â                            	 Â                 0.181	 Â                                      -Â­â€0.148	 Â                                    -Â­â€0.283	 Â                                 0.215**	 Â                                      0.0135	 Â 
                        	 Â                                       	 Â                (0.151)	 Â                                    (0.106)	 Â                                     (0.185)	 Â                                  (0.0767)	 Â                                     (0.0217)	 Â 

             	 Â Municipality	 Â 14	 Â                            	 Â                 0.172	 Â                                    -Â­â€0.00507	 Â                                    -Â­â€0.270	 Â                                  0.0977	 Â                                      0.0150	 Â 
                        	 Â                                       	 Â                (0.151)	 Â                                    (0.0554)	 Â                                    (0.185)	 Â                                    (0.118)	 Â                                    (0.0225)	 Â 

             	 Â Municipality	 Â 15	 Â                            	 Â                 0.182	 Â                                     -Â­â€0.0662	 Â                                    -Â­â€0.276	 Â                                  -Â­â€0.0960	 Â                                   0.0102	 Â 
                        	 Â                                       	 Â                (0.151)	 Â                                   (0.0398)	 Â                                     (0.185)	 Â                                   (0.0710)	 Â                                    (0.0219)	 Â 

              Municipality	 Â 16	 Â                               	 Â                 0.185	 Â                                     -Â­â€0.0859	 Â                                    -Â­â€0.281	 Â                                  -Â­â€0.0807	 Â                                  0.00332	 Â 
                     	 Â                                          	 Â                (0.151)	 Â                                   (0.0517)	 Â                                     (0.185)	 Â                                   (0.0957)	 Â                                    (0.0222)	 Â 
            F	 Â statistic	 Â for	 Â joint	 Â 
                                                                  	 Â                   1.34	 Â 	 Â                                    0.84	 Â 	 Â                                   1.06	 Â 	 Â                                    3.21	 Â 	 Â                                    1.33	 Â 	 Â 
                   significance	 Â 
            Prob	 Â >	 Â F	 Â (p-Â­â€value)	 Â                      	 Â                   0.16	 Â 	 Â                                    0.63	 Â 	 Â                                   0.39	 Â 	 Â                                    0.00	 Â 	 Â                                    0.17	 Â 	 Â 
                Observations	 Â                                   	 Â                81,758	 Â                                      39,730	 Â                                     81,758	 Â                                      19,345	 Â                                      81,758	 Â 
Notes:	 Â The	 Â coefficients	 Â and	 Â standard	 Â error	 Â are	 Â from	 Â regressions	 Â on	 Â the	 Â dependent	 Â variable	 Â listed	 Â at	 Â the	 Â top	 Â of	 Â the	 Â column	 Â controlling	 Â for	 Â 
physician	 Â fixed	 Â effects,	 Â quarter-Â­â€year	 Â for	 Â each	 Â municipality	 Â fixed	 Â effects,	 Â diagnosis	 Â fixed	 Â effects,	 Â and	 Â patient	 Â age	 Â and	 Â sex.	 Â The	 Â sample	 Â is	 Â 
visits	 Â to	 Â clinics	 Â prior	 Â to	 Â the	 Â implementation	 Â of	 Â the	 Â separating	 Â policy	 Â in	 Â the	 Â township	 Â in	 Â which	 Â the	 Â clinic	 Â is	 Â located	 Â for	 Â clinics	 Â that	 Â we	 Â not	 Â 
integrated	 Â at	 Â baseline.	 Â The	 Â standard	 Â errors	 Â are	 Â clustered	 Â at	 Â the	 Â township	 Â level	 Â and	 Â ***	 Â p<0.01,	 Â **	 Â p<0.05.	 Â 
	 Â 
	 Â 




                                                                                                                                                            39
